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Abstract
There are a number of viruses known to be causative agents of cancer (zur 
Hausen, 1991b). Most of these viruses act through expression of proteins that 
interfere with the action of cellular proteins involved in regulating cell division. One 
such family of viruses are the papillomaviruses commonly associated with warts 
and other lesions of epidermal tissues. These viruses have in common a gene 
which encodes a small hydrophobic polypeptide termed E5, so called because it 
encoded by the E5 open reading frame. The E5 proteins are structurally related 
consisting of a hydrophobic N-terminal region but share little sequence homology. 
Nevertheless, they have transforming activity and part of this activity is thought to 
depend upon the binding to another hydrophobic cellular protein, ductin.
Ductin is a component of the vacuolar H+-ATPase (V-ATPase) and the gap 
junction. Whilst gap junction communication is thought to be involved in cellular 
transformation (Stoker, 1967) the ability of the E5 proteins to perturb this cell-cell 
interaction does not correlate with their ability to bind to ductin (Ashrafi et al., 
2000). It, is therefore thought that E5 proteins act through effects on the V- 
ATPase (Harada et al., 1996) since two of the E5 proteins have been shown to 
perturb activities associated with the enzyme (Schapiro etal., 2000; Straight eta!.,
1995). This thesis tests this hypothesis by examining the effects of various forms 
of E5 proteins, including a related protein from a retrovirus (HTLV-1) using 
Saccharomyces cerevisiae as a model organism. Yeast was chosen as it can 
grow in the absence of V-ATPase activity, unlike higher eukaryotic cells, and much
r
is known about its V-ATPase.
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As S. cerevisiae is not the host organism of papillomaviruses and HTLV-1, the 
binding of the E5 proteins to yeast form of ductin was first examined. In an in vitro 
assay using co-translation and immunoprecipitation, all E5 proteins were found to 
bind to the S. cerevisiae form of ductin. When E5 proteins were expressed in S. 
cerevisiae using a vector known to give high expression of membrane proteins, all 
E5 proteins were detected in the vacuoles, a membrane which is the main site for 
the V-ATPase. Monitoring growth of the transformed yeast strains showed the 
expression of E5 proteins was not cytotoxic.
The effects of the E5 transforming proteins were next tested on the activity of the 
S. cerevisiae V-ATPase. This study was extended to include a mutant form of 
ductin in which a key glutamic acid residue (E137) had been changed to glycine 
and is known to act as a dominant negative (Hughes et al, 1996). This mutant 
prevented growth at pH 7.5 and in high extracellular Calcium, both restrictive 
growth conditions that require V-ATPase activity. However, none of the E5 
proteins, despite binding to ductin, had any effect. The enzyme was then 
examined more directly by kinetic analysis of ATP hydrolysis. None of the E5 
proteins perturbed the activity of the V-ATPase as measured by Km or Vmax.
Replacing glucose with galactose/raffinose in the growth medium of yeast reduces 
the V-ATPases activity (Kane, 1995). Repeating these experiments showed an 
initial complete loss of V-ATPase activity but the activity recovered to 
approximately 40% of the original value. This compromised system was therefore 
used to examine any effects of E5 transforming proteins. Whilst the dominant 
negative form of ductin again disrupted growth in the restrictive conditions, none of 
the E5 proteins had any effect.
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The apparent lack of effect on V-ATPase activity by E5 proteins was further 
investigated by examining the locations of the V-ATPase and E5 proteins after 
separation by size fractionation on glycerol gradients after ultracentrifugation. 
This showed that a representative of the E5 transforming proteins, HPV-16 E5, did 
not co-purify with the V-ATPase indicating it became detached from the active 
enzyme. The separation explains why E5 transforming proteins, although capable 
of binding to yeast ductin, do not disturb V-ATPase function.
A partially disabled V-ATPase was used to discover if the E5 proteins could 
disturb activity. This form contained the Norway lobster (Nephrops norvegicus) 
ductin tagged with hexa-histidine tail at the C-terminus, known to markedly elevate 
the Km for ATP (Harrison et al, 1994). Again, the dominant negative form of 
ductin ablated growth at high pH, but none of the E5 proteins had any effect.
Therefore, the E5 transforming proteins do not affect V-ATPase activity and it 
seems likely that their transforming activity is not occurring through the V-ATPase 
as has been thought. A scheme is proposed which takes into account recent 
findings on the related enzyme F-ATPase by which the binding to ductin is part of 
the mechanism of targeting E5 transforming proteins from the Endoplasmic 
Reticulum to other cellular compartments.
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1. Introduction
1.1 General introduction
Cancer is thought ultimately to be the result of the accumulation of genetic lesions 
that lead to permanent stimulation of cell growth and division (Nowell, 1976). 
Such lesions can be caused by a number of agents (carcinogens), all of which act 
by either causing DNA damage directly or by stimulating cell division, increasing 
the probability that naturally-occurring mutations will disrupt the function of 
proteins involved in growth control. Carcinogens are often thought to be toxic 
chemicals, but this is not always the case since some hormones are carcinogenic 
through their ability to stimulate cell division (Henderson etal., 1982).
Similarly, certain viruses are carcinogenic through their ability to stimulate cell 
division. This carcinogenicity can be traced back to individual proteins expressed 
by the viruses, which disrupt the normal scheme of growth regulation in the cell. 
Some of these proteins that cause cell transformation are derived from, or interact 
with cellular proteins involved in growth control (Collett et al., 1978; Downward et 
al., 1984). However, there is a small number of transforming viral proteins whose 
mode of action is not known, such as the E5 group of proteins from the 
papillomaviruses and the type 1 human T-cell lymphotropic viruses.
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1.1.1 Bovine Papillomaviruses
Bovine papillomaviruses are double stranded DNA viruses responsible for benign 
papillomas in cattle (Jarrett, 1985). These papillomas normally regress, but there 
is good evidence to show that some can progress to cause cancer in cattle fed on 
bracken, which contains a number of carcinogens (Campo et al., 1992; Jarrett et 
al., 1978). The six strains of the virus are grouped according to the cell type which 
they infect. Fibropapillomaviruses (types 1, 2 and 5) infect subepithelial 
fibroblasts to produce skin, teat and penis fibropapillomas whereas epitheliotropic 
papillomaviruses (types 3, 4 and 6) infect epithelial keratinocytes to produce 
papillomas of the skin, teat and alimentary canal (Jarrett, 1985).
Viral infection is followed by expression of the early-expressed viral proteins, 
causing transformation of the basal cells to produce a localised thickening, and 
eventually a wart with the normal pattern of cell differentiation (Jarrett, 1985). 
The expression of viral proteins is regulated in line with cell differentiation so that 
viral genome replication is carried out in the intermediate spinous and granular cell 
layers, and capsid proteins are made only in the squamous cells, from which the 
mature virus is released (Anderson et al., 1997). It is this dependence upon cell 
differentiation that has hindered in vitro studies, but sequencing of the viral 
genomes has permitted molecular and genetic analysis, with types 1 and 4 being 
used as candidates for each group in this discussion.
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1.1.1.1 Bovine papillomavirus type 1
Subcutaneous injections of bovine papillomavirus type 1 (BPV-1) cause tumours 
in pika, domestic rabbits and hamsters (Breitburd et al., 1981; Koller and Olson, 
1972; Puget et al., 1975). Murine fibroblasts transformed by the virus are 
tumourigenic in nude mice (Mantyjarvi et al., 1988), yet in the natural host, 
infection only causes benign papillomas of the skin, teat frond or penis. This 
supports the idea that the cell transformation is an integral part of the life cycle of 
papillomaviruses but carcinogenesis is confined to instances when the 
interrelationship between virus and host is disrupted. This could either be due to 
the presence of external carcinogens, as mentioned previously, or by integration 
of the viral DNA into the host genome, disrupting the tight transcriptional 
regulation of the virus that normally prevents cell transformation from 
overprogression (Couturier et al., 1991).
1.1.1.1.1 Organisation of the BPV-1 genome
A map of the genome is shown in Figure 1.1. Sequence analysis has identified 
the position of open reading frames (Chen et al., 1982) and found similarities to 
the organisation of the human papillomavirus type 1 genome, later expanded to a 
common plan for all papillomaviruses (Danos et al., 1984), supporting the idea of 
a common ancestor and more importantly, a similar mode of cell transformation.
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Figure 1.1 Organisation of the BPV-1 genome
Reading frames are indicated in the leftmost column. The long control region (LCR) controls the 
expression of early (E) and late (L) proteins, with promoters denoted by asterisks. Adapted from 
(Campo, 1988).
The early-expressed (E) proteins are those involved in cell transformation and viral 
replication whereas the two late proteins are the capsid proteins for packaging the 
virus before release. The long control region (LCR) between late and early open 
reading frames contains the origin of replication, and regulatory elements that co­
ordinate the expression of the viral proteins via proximal and distal promoters. 
The majority of mRNA species are initiated at promoters inside or near to the 
LCR, with RNA splicing used to direct translation rather than individual promoters, 
reviewed by Lambert et al., (1988).
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1.1.1.2 Bovine papillomavirus type 4
Bovine papillomavirus type 4 (BPV-4) is a representative of the group B 
papillomaviruses (Jarrett, 1985), causing ‘true’ epitheilotropic papillomas by 
infection of basal cell keratinocytes. It shares many of the features of BPV-1. 
Both size and organisation of the genome are very similar (Patel et al., 1987), the 
only major difference being the substitution of two major transforming proteins: E5 
and the E6 for an E5 homologue, E8. This feature is shared with the other two
members of the viral subtype and may account for the differences between the 
two groups. In addition, whilst BPV-1 is capable of transforming primary 
fibroblasts independently (M S Campo, personal communication), BPV-4 requires 
an activated form of ras (a GTPase involved in signal transduction from growth 
factor receptors), reviewed by Wittinghofer, (1998) to cause transformation 
(Jaggar etal., 1990).
1.1.2 Human papillomaviruses
The human papillomaviruses have a similar genetic organisation to BPV-1 (Figure 
1.1) and are divided into two main groups: those that infect cutaneous epithelia to 
produce skin warts, and those that infect mucosal epithelia, which give rise to 
anogenital warts. In addition, these groups are subdivided into high risk and low 
risk subtypes, according to the chance of malignant transformation, see (zur 
Hausen and de Villiers, 1994). For the purposes of cancer research, it is the 
mucosal viruses (particularly the high risk types, 16 and 18) that are given the 
most attention, these being found in the majority of all cervical carcinoma biopsies 
(Walboomers etal., 1999).
Further evidence for the causal role of HPV in human cancer comes from the
discovery of transcripts for the major viral transforming proteins, E6 and E7 in
most cervical tumours (Schwarz et al., 1985) and that the transformation potency
of these proteins correlates with the risk category of their virus (Munger et al.,
1989). However, the most convincing evidence comes from the observation that
these transformed cells become malignant after extended cultivation In vitro
(Pecoraro et al., 1991), analogous to the proposed in vivo scheme of HPV (and
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BPV) initiated carcinogenesis where infection is followed by a period of 
progression to the malignant phenotype (zur Hausen, 1991a).
1.1.3 Functional aspects of the papiilomaviral proteins
The similarities in the genome organisation of the papillomaviruses suggests that 
they cause cell transformation by similar mechanisms. All of the viruses possess 
an open reading frame (ORF) for a small hydrophobic transforming protein, which 
together form the ‘E5’ family of proteins. Their mode of cell transformation is 
unknown, but reviewing what is known about the products from the other viral 
ORFs places the E5 proteins in context and aids their investigation.
1.1.3.1 The E1 ORF
The E1 ORF of the human papillomavirus is thought to be required for viral 
replication (Gopalakrishnan and Khan, 1994), the E1 ORF of BPV-1 coding for two 
products involved in viral replication (Lusky and Botchan, 1986); the E1 modulator 
(E1-M) and the E1 replicator (E1-R). E1-R is the helicase responsible for 
replication of the genome (Thorner etal., 1993) whereas E1-M is thought to act as 
a negative regulator of replication (Berg etal., 1986). One difference between the 
E1 proteins of bovine and human papillomaviruses is that although BPV-1 E1 is 
involved in transcriptional regulation (Sandler et al., 1993), a similar activity has 
not been found for E1 of the human papillomaviruses.
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1.1.3.2 The E2 ORF
The product of the E2 ORF binds to E1 in the replication complex (Benson and 
Howley, 1995; Frattini and Laimins, 1994). As well as participating in replication, 
E2 has been shown to regulate transcription (Bernard et al., 1989; Jackson and 
Campo, 1991; Phelps and Howley, 1987). In BPV-1 this is due to the translation 
of two shorter E2 transcripts which act as repressor proteins (Lambert et al., 
1987), further analysis revealing phosphorylation sites on all three types (McBride 
et al., 1989), implying cellular regulation of their activity. The complexity of E2- 
mediated transcriptional regulation is expanded by the discovery that the three 
types possess different nuclear localisation signals (Skiadopoulos and McBride,
1996) and that cellular transcription factors also compete for binding sites on the 
LCR (Jackson and Campo, 1995). Evidence for REDOX regulation has also been 
found (McBride et al., 1992), somewhat reminiscent of V-ATPase regulation 
discussed in section 1.3.6.4, but the functional significance of this is not known.
1.1.3.3 The E4 ORF
Disruption of the BPV-1 E4 reading frame has no effect on transactivation, 
replication, or cell transformation (Neary et al., 1987). From its abundance in 
HPV-1a infected cells during capsid synthesis (Doorbar et al., 1986) it was 
inferred to be involved in the late gene expression. One possibility is that the E4 
products directly regulate the late expression promoter, supported by observations 
that the E4 products are zinc-binding proteins and are liable to phosphorylation 
(Grand etal., 1989; Roberts etal., 1994).
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1.1.3.4 The E6 ORF
The product of the human papillomaviral E6 ORF has been characterised the 
most extensively. Its transforming ability was discovered by viral expression 
studies in human primary fibroblasts (Watanabe et al., 1989). Although E7 is also 
required to effect this transformation in human cell lines (Munger et al., 1989), in 
murine cells persistent E6 expression is capable of causing not only 
transformation, but tumour formation in vivo (Song et al., 1999).
E6 is thought to bind to and promote degradation of p53 (Scheffner et al., 1990; 
Werness et al., 1990), which normally protects the cell from mutations by causing 
cell cycle arrest or apoptosis in the event of DNA damage. In agreement with this 
mechanism of cell transformation, chromosome damage has been found in E6- 
transformed cells (Coursen et al., 1997), and E6 expression has been shown to 
abrogate checkpoints in the cell cycle in a manner dependent upon p53 binding 
and degradation (Thompson et al., 1997). However, dominant negative p53 
mutations do not fully substitute for E6 (Sedman et al., 1992), suggesting that it 
has other functions.
E6 has also been shown to act as a transcription factor (Akutsu et al., 1996; 
Etscheid et al., 1994; Patel et al., 1999), in line with its predicted structure, 
possessing two DNA-binding zinc finger domains at its N-terminus (Barbosa et al., 
1989). It has also been shown to activate telomerase (Klingelhutz et al., 1996), a 
chromosome repair enzyme that is typically upregulated in immortal cell lines.
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BPV-1 E6 has also been studied, and appears to act in a different manner to that 
of HPV-E6, being involved in, but not essential for cell transformation (Neary and 
DiMaio, 1989). It is capable of causing cell transformation in vitro (Androphy et 
al., 1985), but through a mechanism involving both transcriptional activation. 
(Chen et al., 1997; Ned et al., 1997; Vousden et al., 1989) and binding to 
cytoskeletal and vesicular proteins (Tong etal., 1998; Tong eta l., 1997).
1.1.3.5 The E7 ORF
Early studies in NIH 3T3 cells established the product of the E7 ORF as the major 
transforming protein of HPV-16 (Vousden et al., 1988). Unlike E6, retrovirally- 
expressed E7 is capable of immortalising human fibroblasts (Halbert et al., 1991) 
albeit more efficiently in the presence of E6.
Three domains have been identified which give clues as to its mode of action: a 
retinoblastoma protein (Rb) binding domain (Dyson et al., 1989), two zinc fingers 
(Barbosa etal., 1989) and substrate sites for protein kinase C and caesin kinase II 
(Armstrong and Roman, 1995; Firzlaff et al., 1989). The Rb-binding activity is 
thought to contribute towards cell transformation by preventing Rb from binding to 
transcription factors such as elongation factor 2 (Zerfass et al., 1995), which is 
implicated in the regulating the transcription of a number of genes required for cell 
cycle progression (Degregori et al., 1995). Rb binding potential correlates with the 
transforming ability of E7 and even the risk classification of the virus (Heck et al.,
1992) but additional activities are required to effect transformation by the protein
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(Banks et al., 1990), one possibility being the involvement of Cys-X-X-Cys zinc 
finger motifs.
DNA-binding has been demonstrated for E7 (Chinami et al., 1996) but its role in 
transformation is unclear (Braspenning et al., 1998; McIntyre et al., 1993). The 
involvement of E7 phosphorylation sites seems to correlate with transforming 
ability (Armstrong and Roman, 1995; Firzlaff et al., 1991), probably due to 
activation of other domains of the protein. Other binding partners involved in 
transcriptional regulation and cell proliferation have also been found: AP1 
transcription factors (Antinore et al., 1996), the TATA box binding protein 
(Massimi et al., 1997) and members of the cyclin system (Massimi et al., 1997). 
So it seems that the E7 has a complex mode of cell transformation.
Although the majority of work has been carried out on the human papillomaviral 
E7, sequence similarities between the bovine and human types suggesting similar 
functions. Presence of zinc finger motifs in BPV-1 E7 (Barbosa et al., 1989) is 
consistent with a mode of action via DNA binding, however despite the 
requirement for E7 in cell transformation by BPV-1 (Neary and DiMaio, 1989), 
BPV-1 E7 is believed to be involved in maintaining the viral copy number rather 
than transformation per se (Jareborg etal., 1992; Lusky and Botchan, 1985).
In BPV-4, E7 is the major transforming protein, capable of causing 
morphologically transformation in the presence of activated ras (Pennie et al.,
1993) and thought to act via DNA-binding zinc fingers and a Rb-binding domain 
(Jaggar et al., 1990). However, this remains to be proven.
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1.1.3.6 The L1 and L2 ORFs
These reading frames encode the two capsid proteins that are expressed before 
the virus is shed in the squamous layer (Zhao et al., 1998). Although not 
important for transformation, they have been useful for production of a BPV-4 
vaccine (Chandrachud et al., 1995), and may prove useful for construction of 
vectors for gene therapy (Zhao et al., 1998).
1.1.3.7 Summary
The papillomaviruses are double stranded DNA viruses which encode at least one 
transforming protein in addition to an E5 protein. A similar situation is also found 
in an otherwise unrelated retrovirus, the human T-cell lymphotropic type 1 virus.
1.1.4 Human T-cell lymphotropic virus type 1
The human T-cell lymphotropic type 1 (HTLV-1) virus is a enveloped double­
stranded RNA retrovirus which infects T-lymphocytes to produce a range of 
diseases, for review see (Uchiyama, 1997). It is concentrated in Africa, central 
America and Japan, which is probably a consequence of the proposed mode of 
establishment by initial transmission from simians to humans in Africa and 
subsequent dispersion of population by the slave trade (Gallo et al., 1983). The 
diseases themselves are more of a burden than a threat, but understanding the 
biology of the virus may aid research into the type III lymphotropic virus, the
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human immunodeficiency viruse (HIV) which is believed to cause acquired 
immune deficiency syndrome (AIDS).
Despite infecting lymphocytes, it is rare for the associated leukaemia to develop 
into a pathological form. Adult T-cell leukaemia only develops in around 0.1% of 
carriers after a long latency period (average age at onset is 55) (Tajima, 1990). 
This is reminiscent of papillomaviral-induced cancer, and indeed of any productive 
relationship of a virus with its host. The amount of biochemical interference by the 
virus appears sufficient to maximise production of the virus, without causing death 
of the host and affecting viral propagation.
Lymphocyte disorders in the cerebrospinal fluid are thought to cause HTLV-1- 
associated myelopathy (HAM), also called tropical spastic paraperesis (TSP) 
(Osame etal., 1986). This is a neurological disorder reducing control and sensory 
functions in the lower half of the body. As well as being debilitating, an increased 
risk of infections and cancer accounts for an average morbidity period of ten years 
(Osame et al., 1990).
Joint disorders in infected patients led to the proposition of HTLV-1-associated 
arthropathy (HAAP) (Nishioka et al., 1989). In much the same way, a form of 
uveitis has also been attributed to HTLV-1 (Mochizuki et al., 1992). There is also 
evidence to suggest a link between HTLV-1 and other diseases (Kimura et al., 
1986; LaGrenadeetal., 1990; Morgan etal., 1989; Ohshimaetal., 1992). None of 
these are associated with morbidity, but some bear symptoms similar to those of 
other autoimmune diseases such as chronic arthritis and atopic dermatitis, so it 
may be possible to combine the lessons learnt from both fields.
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1.1.4.1 HTLV-1 genome organisation and protein function
The viral genome is illustrated in Figure 1.2. The viral RNA is 9 kilobases long, 
with 2 long terminal repeats (LTRs), 6 main coding domains (gag, env, pol, pro, 
tax, rex) and a short 3’ ‘end region’ that encodes three more proteins with 
unknown functions (Seiki et al., 1983). The retroviral life cycle has been reviewed 
by Varmus, (1988), it being distinct from that of DNA viruses in that the RNA 
genome must be reverse transcribed into a DNA ‘provirus’ before any viral 
proteins can be synthesised. To this end, the viral RNA is already primed with 
both DNA template and reverse transcriptase, the enzyme being activated when 
the viral capsid is exposed to the cellular cytoplasm. An integrase then inserts the 
provirus into the host genome and the viral genes are finally transcribed under the 
direction of the LTRs.
p19 p24 p12
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Figure 1.2 Genome organisation of HTLV-1
I
9kb
Reading frames indicated on the left. The long terminal repeats (LTRs) contain the viral promoters, 
gag, pro, pol and env encode structural and enzymic proteins, tax and rex encoding the major 
transforming proteins. Adapted from (Franchini, 1995).
29
1.1.4.1.1 The gag, pro, env, pol ORFs
The gag/pro ORF encodes the two capsid proteins, p19 and p24 as well as the 
p12 protease which is involved in viral protein maturation (Hatanaka and Nam,
1989). Env encodes the two envelope glycoproteins, gp21 and gp46 (Hattori et 
al., 1984), which are most likely to be the cell surface receptors although their 
target is not known. Pol encodes the viral reverse transcriptase and the integrase 
(Netzer etal., 1993).
1.1.4.1.2 The Tax and Rex ORFs
These ORFs encode two proteins involved in transcriptional regulation, tax and 
rex. Two reviews deal with them thoroughly (Franchini, 1995; Uchiyama, 1997) 
and they will be dealt with briefly here.
Tax and rex are phosphoproteins that regulate viral transcription via the LTRs 
(Sodroski et al., 1984) to produce sporadic expression patterns that have been 
proposed to hinder immune detection (Franchini, 1995). Tax interacts with many 
cellular transcription factors to upregulate the transcription of a number of cellular 
proteins, most of which being directly implicated in cell proliferation, e.g. the 
interleukin 2 receptor and the c-fos transcription factor (Franchini, 1995). Unlike 
rex, tax has been shown to immortalise mitogen-activated human T-cells 
(Grassmann et al., 1989). The most likely reason for this is that rex seems only to 
regulate viral transcription; it upregulates gag, pol and env transcription as well as
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genomic RNA synthesis, but downregulates tax and rex transcription (Yoshida et 
al., 1994), in line with the sporadic expression patterns of the virus.
1.1.4.1.3 The pX region
Tax and rex are partly coded by a region denoted ‘pX’. This also encodes three 
other proteins: p30” , p13” and p12\ Very little is known about these products; 
p30” and p13” have been detected in the nucleus of transfected cells, but do not 
affect tax or rex transcriptional regulation (Roithmann et al., 1994). The only 
evidence on their function comes from the high nonsense mutation frequency of 
p13” and p30” , implying that they are of limited importance. p12* bears similarities 
to the papillomaviral E5 proteins and is discussed below.
1.1.5 The E5 proteins: a structurally related family of proteins with a 
conserved cellular binding partner
All of the viruses described previously encode at least one transforming protein. 
They also encode a small hydrophobic transforming protein which acts by an 
unknown mechanism. These proteins: BPV-1 E5, BPV-4 E8, HPV-16 E5 and 
HTLV-1 p121 (hereon termed ‘E5 proteins’) have structural similarities and bind to 
ductin, (a proteolipid component of the V-ATPase, mediatophore and gap 
junction), suggesting a similar mode of cell transformation.
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1.1.5.1 BPV-1 E5
This encodes a 7kDa hydrophobic transforming protein (Figure 1.3). Although E6 
is also involved in cell transformation (section 1.1.3.4), mutational analysis of E5 
showed that it is essential for cell transformation by the virus (DiMaio et al., 1986). 
Subsequent studies showed it alone to be capable of transforming a number of 
different cell lines (Bergman etal., 1988; Leptak et al., 1991; Schiller etal., 1986). 
In searching for its mechanism of cell transformation, four binding partners have 
been identified: the platelet derived growth factor receptor beta (PDGF-R) (Petti 
and DiMaio, 1992), the epidermal growth factor receptor (EGF-R) (Cohen et al., 
1993a), an alpha adaptin homolog, p125 (Cohen et al., 1993b) and ductin, a 
proteolipid component of the vacuolar ATPase, gap junction and mediatophore 
(Goldstein et al., 1991).
Association with the PDGF-R causes receptor dimerisation and activation in the 
absence of growth factor (Drummond-Barbosa et al., 1995; Lai et al., 1998), with 
transformation depending upon this activation (Nilson et al., 1995; Riese and 
DiMaio, 1995). Mutational analysis has shed light on the significance of the 
carboxy terminal domain, with crucial residues being conserved across 
papillomaviruses from four animal species (Horwitz et al., 1988), and also to a 
limited extent with the extracellular domains of two forms of PDGF-R (Meyer et al., 
1994). Of particular note was the dependence upon an aspartic acid residue, 
presumed to participate with a lysine residue in PDGF-R to mediate binding (Klein 
et al., 1999; Petti et al., 1997) and also upon two cysteine residues which permit 
E5 (and therefore PDGF-R) dimerisation (Horwitz et al., 1988). However, the 
carboxy-terminal domain also mediates binding to the alpha adaptin homologue
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(Cohen et al., 1993b), which could contribute to cell transformation through effects 
on vesicle trafficking.
More elusive is the role of the transmembrane domain of E5. This mediates E5 
binding to ductin and PDGF-R (Goldstein et al., 1992a; Petti et al., 1997), but 
neither of these activities correlated completely with transforming ability 
(Sparkowski et al., 1996). The glutamine residue at position 17 is thought to 
mediate the interaction with ductin via the active glutamic acid residue in the fourth 
helix of ductin (Figure 1.7) (Andresson et al., 1995; Goldstein et al., 1992b). 
Disruption of this interaction by mutation of the glutamine tended to reduce the 
transforming potential of E5 in NIH 3T3 cells (Sparkowski et al., 1994), but 
expression in C127 cells revealed a number of hypertransforming mutants, all of 
which had polar residues of a similar size to glutamine, suggesting a role for this 
residue in forming hydrogen bonds (Sparkowski et al., 1994). This was confirmed 
by more extensive mutagenesis studies, which demonstrated the correlation 
between hydrogen bonding capacity, PDGF-R binding and activation, and C127 
cell transformation (Klein etal., 1998).
However, earlier studies on E5 truncations showed the glutamine to have only a 
minor effect on transforming activity, the majority being confined to the carboxy- 
terminal (C-terminal) region (Rawls et al., 1989). Also, partial substitution of the 
hydrophobic domain with that of a receptor tyrosine kinase, neu (Coussens et al., 
1985) did not abolish transforming activity despite the normally disruptive 
substitution of glutamine 17 for leucine (Meyer et al., 1994).
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Alanine scanning mutagenesis was performed to correlate the activity of 
transmembrane residues with respect to mediating the binding activities of E5, 
the phosphorylation of PDGF-R, and the transformation of NIH 3T3 cells. (Adduci 
and Schlegel, 1999). The residues involved in mediating the binding of E5 to itself 
and PDGF-R aligned to form distinct regions on a helical wheel projection, 
supporting the assumption that the transmembrane domain is a-helical in 
structure, and demonstrating the specificity of the interactions of E5. Mutations 
that prevented either binding activity prevented PDGF-R phosphorylation, but had 
no consistent effect on the transforming potential (Adduci and Schlegel, 1999). 
One proposal was that phosphorylation-defective E5 mutants transformed cells 
through their ability to form tetrameric membrane pore complexes (Adduci and 
Schlegel, 1999).
The role of ductin in the mode of action of E5 has not been investigated to the 
same extent. Ductin binds to E5 and PDGF-R (Goldstein et a!., 1992a; Goldstein 
et al., 1991) and was suggested to mediate the binding of the proteins to each 
other, since the ability of E5 to bind ductin and PDGF-R were related, and a stable 
complex of the three proteins was found (Goldstein et al., 1992a). Ductin mutants 
have also demonstrated an indirect link between E5 binding and cell 
transformation; mutation of the active glutamic acid not only preventing the binding 
to E5, but converted ductin into a transforming protein (Andresson etal., 1995).
BPV-1 E5 may act in the Golgi, since its retention in the endoplasmic reticulum 
(ER) prevented cell transformation (Sparkowski et al., 1995), and it has also been 
shown to inhibit acidification of the Golgi apparatus in a manner that corresponded 
with its ability to transform NIH 3T3 cells (Schapiro et al., 2000). Despite its
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similarity to the influenza virus M2 and the adenovirus E3 channel-forming 
proteins, which exhibit some of the cellular effects of E5 (Henkel et al., 1999; 
Hoffman and Carlin, 1994), BPV-1 E5 did not affect the permeability of the Golgi 
membrane to protons (Schapiro et al., 2000), suggesting that it dissipated Golgi 
pH by a different mechanism. In the light of this, and data dissociating PDGF-R 
activation from cell transformation (Leptak et al., 1991; Sparkowski et al., 1996), it 
was suggested that E5 inhibited the V-ATPase through its interaction with ductin 
(Schapiro etal., 2000).
1.1.5.2 HPV-16E5
HPV-16 E5 was identified as an oncogene by its ability to induce anchorage- 
independent growth upon NIH 3T3 cells (Leechanachai et al., 1992). It does not 
transform cells to the same extent as E6 or E7 (Rho et al., 1996), appearing to 
carry out more of an accessory role in transformation of primary cells (Stoppler et 
al., 1996). Just like the bovine papillomaviral E5 and E8 proteins, HPV E5 
proteins are highly hydrophobic with conserved cysteines (only 1 in the case of 
HPV-16 E5) in the C-terminal domain (Bubb et al., 1988). There are important 
differences though; the HPV E5 proteins are predicted to possess an additional 
transmembrane domain and lack the active amido group found at position 17 of 
BPV-1 E5 and BPV-4 E8 (Bubb etal., 1988).
HPV-16 E5 has been shown to bind to a number of growth factor receptors 
(Hwang et al., 1995); EGF-R and PDGF-R, as for BPV-1 E5, but also colony 
stimulating factor receptor, which regulates phagocyte proliferation (Nagata and
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Fukunaga, 1993) and p185netv, a proto-oncogene involved in modulating the 
affinity of EGF-R for EGF (Stern et al., 1988; Wada et al., 1990). There is 
evidence to suggest that the interaction with EGF-R may contribute to cell 
transformation (Crusius etal., 1998; Pirn etal., 1992), however the involvement of 
PDGF-R is uncertain, since another study showed that only the low risk type HPV- 
6 E5 could interact with this receptor (Conrad etal., 1994).
HPV-16 E5 also binds to ductin (Conrad et al., 1993). This binding has been 
shown not only to inhibit gap junctional communication independently of connexin 
phosphorylation (Oelze et al., 1995), but to inhibit activities reliant on the V- 
ATPase; endosome acidification and EGF-R degradation (Straight et al., 1995). 
However, whether this is due to a direct inhibition of the enzyme remains to be 
shown..........................................................................................................................
1.1.5.3 BPV-4E8
Despite being found where the E6 ORF would be expected, the E8 ORF encodes 
a protein with homology to the BPV-1 E5 protein (Figure 1.3) (Jackson et al.,
1991). E8 has the same cellular localisation pattern as BPV-1 E5 (Anderson et 
al., 1997), and is capable of conferring anchorage independent growth upon 
primary bovine fibroblasts containing activated ras (Pennie et al., 1993). However, 
it is not found in the differentiated cell layers in which BPV-1 E5 is found (Burnett 
et al., 1992) and there are no data to suggest that it binds to or activates growth 
factor receptors.
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Mutational studies on E8 show both similarities and differences between the two 
proteins, for example the glutamine at position 17 in BPV-1 E5 is asparagine in 
E8. These residues share the same functional group but mutation of the BPV-1 
E5 glutamine to asparagine disrupts the function of the protein (Sparkowski et al., 
1994) and mutation of the E8 asparagine reveals different requirements to that of 
E5; small hydrophobic residues as opposed to medium sized polar residues 
(O'Brien et al., 1999). Domain swaps between the two proteins showed that only 
the hydrophobic domain of BPV-1 E5 can substitute for that of E8 (O'Brien et al., 
1999). Suggesting that not only is the C-terminal domain of E8 implicated in its 
mechanism of transformation, but that it acts in a way distinct from that of BPV-1 
E5; a conclusion supported by poor C-terminal sequence homology, lack of 
growth factor receptor binding by E8 and the observation that, unlike BPV-1 E5, 
E8 upregulates cyclin A and its associated kinase (O'Brien and Campo, 1998).
In fact, the only evidence that they may have a similar mechanism for cell 
transformation comes from the fact they both bind to ductin and inhibit gap 
junctional intercellular communication (Ashrafi et al., 2000; Faccini et al., 1996). 
However, the transforming abilities of BPV-4 E8 mutants did not fully correlate 
with their effects on communication (Ashrafi et al., 2000) so it is unlikely that this 
plays a major part in the mechanism of cell transformation. Another possibility is 
that E8 transforms cells by upregulating Cyclin A (O'Brien and Campo, 1998), 
since this protein is involved in cell cycle checkpoints and has been implicated in 
carcinogenesis (Desdouets etal., 1995).
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1.1.5.4 HTLV-1 p12'
p12f is implicated in the maintenance of viral infection (Collins et al., 1998). Its 
precise role is not known although it has been shown to bind to and disrupt the 
targeting of the interleukin-2 (IL-2) receptor (Mulloy et al., 1996) as well as binding 
to ductin (Franchini et al., 1993). Its interaction with the IL-2 receptor could lead to 
hyperproliferation and therefore positive selection for infected cells, but evidence 
to suggest that its interaction with ductin could be involved comes from studies 
showing that not only does it exhibit sequence similarities with BPV-1 E5 (Figure 
1.3), but also co-operates with it in cell transformation (Franchini et al., 1993; 
Garry, 1995). However, the mode of binding to ductin appeared to be different to 
that seen for BPV-1 E5, and co-operation of two proteins does not indicate 
whether they act by similar mechanisms.
1.1.5.5 Ductin binding may represent a common mode of cell transformation
The structural similarities of the E5 proteins have been documented previouslyi
(Bubb et al., 1988; Franchini et al., 1993; Garry, 1995), and are illustrated by 
hydrophobic cluster analysis (Gaboriaud et al., 1987) in Figure 1.3. The a-helical 
prediction is supported by genetic and physical structural analysis of BPV-1 E5 
(Adduci and Schlegel, 1999; Surti et al., 1998), and despite the overall lack of 
sequence homology, the presence of ‘LLF’ motifs in similar positions in the 
proteins would support the belief that they have similar structures.
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Despite the fact that most of the E5 proteins have been found to bind to growth 
factor receptors, (Goldstein et al., 1992a; Hwang et al., 1995; Mulloy et al., 1996), 
this activity does not always correlate with their transforming potential (Nilson and 
DiMaio, 1993; Sparkowski etal., 1996), so may not represent the conserved mode 
of action suggested by the structural conservation. However, all of the proteins 
bind to ductin (Conrad et al., 1993; Faccini et al., 1996; Franchini et al., 1993; 
Goldstein et al., 1991), which as mentioned above is a proteolipid component of 
gap junctions and the vacuolar ATPase. Both of these have been implicated in 
growth control. (Harada et al., 1996; Stoker, 1967), but it is not known if they are 
involved in the mechanism of cell transformation by the E5 proteins.
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Figure 1.3 Structural similarities of the E5 proteins
The protein sequences of the E5 proteins were analysed by hydrophobic cluster analysis 
(Gaboriaud et al., 1987), which arranges the residues an an a-helical array and outlines any 
hydrophobic regions. The sequences were aligned according to the position of predicted 
transmembrane domains (denoted by grey boxes, underneath).
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1.2 Ductin is a multifunctional pore protein and a possible tumour 
supressor protein
Because the E5 proteins bind to ductin, it suggests that it is involved in their 
mechanism of cell transformation. Evidence for this comes from experiments 
showing that not only does ductin expression suppress transformation by BPV-1 
E5, but it is capable of transforming NIH 3T3 cells when expressed in a dominant 
negative form (Andresson et al., 1995). However, just how it is involved is 
unclear, since ductin is found in three cellular structures, the vacuolar ATPase (V- 
ATPase), the gap junction, and the mediatophore, (Brochier and Morel, 1993; 
Finbow et al., 1983; Mandel et al., 1988). Both the gap junction and the V- 
ATPase are implicated in growth control, and so suggest potential mechanisms for 
the action of the E5 proteins.
1.2.1 Gap junctional intercellular communication and tumour suppression
Metazoan tissue function relies on the co-operation of its constitutive cells and this 
is achieved in part by gap junctional intercellular communication (GJIC); the 
passive diffusion of low mass solutes (<1.5kDa) through transmembrane channels 
known as gap junctions (Finbow and Pitts, 1981). Intercellular communication 
through gap junctions is required during embryonic development (Allen et al.,
1990), and co-ordinates cellular activities such as cardiac muscle contraction 
(Oyamada etal., 1994) and cell proliferation (Pitts et al., 1988).
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Electron microscopy of isolated gap junctions revealed that the constituent 
proteins are arranged in hexagonal arrays to form hemi-channels which appose 
each other to form the complete channel (Hoh et al., 1991). A number of proteins 
have been characterised from preparations of gap junctions, the largest and best 
characterised group being the connexins, reviewed by Goodenough et al., (1996). 
These are predicted to be integral membrane proteins with 4 transmembrane 
alpha helices, with both termini facing the cytoplasm (Goodenough et al., 1996). 
Ductin is another component of gap junctions (see section 1.3.5.3.4 for structural 
information), which unlike connexins is found in both vertebrates and invertebrates 
(Finbow, 1997). A pure preparation of ductin has the microscopic structure of the 
gap junction (John et al., 1997), and antisera raised against ductin inhibit GJIC in 
mollusc, insect and mammalian cells (Bohrmann, 1993; Finbow et al., 1993; 
Serras et al., 1988), but there is no genetic evidence to prove that it is an active 
component of the gap junction. Another group of proteins have also been 
proposed as components of the invertebrate gap junction, the innexins (Phelan et 
al., 1998). These are predicted to be of similar structure to connexins, but have 
no sequence homology to them or any other vertebrate protein.
A role for gap junctions in the control of cell proliferation was first suggested by 
(Lowenstein and Kanno, 1966), later reinforced by observations of antiproliferative 
effects of connexins expressed either inside transformed cells or in those adjacent 
to transformed cells (Rose et al., 1993). One suggestion is that GJIC disperses 
second messengers that appear in a cell after stimulation with growth factors, 
(Loewenstein, 1979), this dilution attenuating the response of the individual cell to 
stimulation. So if a cell loses its ability to communicate with its neighbours then its 
sensitivity to growth stimuli will be enhanced.
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Indeed, reduced GJIC is observed in many tumours, (Lowenstein and Kanno, 
1966), and many tumour promoters have been shown to reduce GJIC in vitro 
(Enomoto et al., 1981; Murray and Fitzgerald, 1979). However, although tumour 
cells may communicate poorly with non-tumour cells, communication within the 
tumour may be more efficient (Mesnil and Yamasaki, 1996). This suggests that 
tumours act like separate tissues, being separate communication compartments 
rather than simply a mass of non-communicating cells.
BPV-1 E5, BPV-4 E8 and HPV-16 E5 have all been shown to inhibit GJIC (Ashrafi 
et al., 2000; Faccini et al., 1996; Oelze et al., 1995), but mutational analysis of 
BPV-4 E8 showed that this ability did not correlate cell transformation (Ashrafi et 
al., 2000; O'Brien et al., 1999). Similarly, the effect of the tumour promoter 12-0- 
tetradecanoylphorbol-13-acetate (TPA) on junctional communication was different 
when measured in vivo and in vitro (Kam and Pitts, 1988; Pasti et al., 1988), 
suggesting that the relationship between GJIC and cell transformation is complex. 
It also appears that GJIC is regulated by a number of mechanisms (Azarnia et al., 
1988; Jongen et al., 1991; Kanemitsu and Lau, 1993), further complicated by the 
number of proteins implicated in the formation of gap junctions. Because of this 
complexity, it seems that GJIC is unsuitable for studying the role of ductin binding 
in the mechanism of cell transformation by the E5 proteins.
However, ductin is known to be an essential component of the vacuolar ATPase 
(Umemoto et al., 1990), which is directly linked to growth regulation through its 
maintenance of the endocytic pathway (Mellman, 1992), which downregulates cell 
stimulation by growth factors. Measuring disturbances of the V-ATPase may
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provide a simpler way to investigate the significance of ductin binding by the E5 
proteins in their mode of cell transformation
1.2.2 The vacuolar ATPase and the regulation of cell signalling by 
endocytosis and degradation of growth factor receptors
Growth stimulation in eukaryotes begins with the binding of a growth factor to its 
receptor. There are various mechanisms that translate this binding into a cascade 
of biochemical events, (commonly protein phosphorylation), which end in the 
specific redirection, or maintenance of cellular activity ascribed to the growth 
factor (van der Geer et al., 1994). However, the cell surface receptors must be 
continually refreshed in order to respond to the dynamic environment of growth 
factors, which is achieved by endocytosis and subsequent processing of the 
receptors. This has been reviewed extensively (Gruenberg and Maxfield, 1995; 
Mellman, 1992; Sorkin and Waters, 1993) and shall be covered briefly here.
1.2.2.1 Structure of growth factor receptors
The epidermal growth factor receptor (EGF-R) is one of the most popular models 
(van der Geer et al., 1994). It consists of four key domains:
• A cytoplasmic tyrosine kinase domain (Chinkers and Brugge, 1984) that is 
activated by EGF binding, which phosphorylates cellular proteins including 
other growth factor receptors (Yarden and Schlessinger, 1985).
• A transmembrane domain, which anchors the protein in the membrane.
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• A heavily glycosylated extracellular EGF-binding domain (Lax et al., 1990; Lax 
et al., 1989) which presumably changes conformation upon binding in such a 
way as to activate the kinase domain.
• A cytoplasmic internalisation domain involved in inducing endocytosis of the 
receptor upon epidermal growth factor (EGF) binding (Chang etal., 1993).
1.2.2.2 Receptor mediated endocytosis
The phenomenon of ‘growth factor-induced receptor downregulation’ was first 
reported in 1976 (Carpenter and Cohen, 1976), where EGF addition to cells 
caused an 80% decrease in their subsequent binding capacity. This was 
attributed to receptor internalisation and degradation, eventually leading to the 
term of ‘receptor-mediated endocytosis’.
The scheme of receptor mediated endocytosis and receptor processing is shown 
in Figure 1.4. As well as triggering a cascade of protein phosphorylation, binding 
of EGF to its receptor is also thought to activate the internalisation domain, with 
autophosphorylation contributing to this (Sorkin et al., 1992). Once activated, the 
receptor complexes are recruited to clathrin-coated pits in the membrane via the 
association of the internalisation domain with a clathrin-binding protein complex 
called ‘adaptor-protein complex 2’ (AP-2) (Sorkin etal., 1995). These pits bud off 
and fuse with other vesicles to form early endosomes (Figure 1.4 A), and receptor 
processing begins.
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1.2.2.2.1 Sorting in the early endosomes
The early endosomes are tubo-vesicular membrane structures with an internal pH 
of 6.2 (Tooze and Hollinshead, 1991) which is generated by the action of the 
vacuolar ATPase (V-ATPase) (Galloway et al., 1983). Both of these features have 
been implicated in its role of sorting proteins for degradation or recycling to the cell 
surface (Linderman and Lauffenburger, 1988). Acidic pH causes dissociation of 
ligands from their receptors (Davis et al., 1987) and the tubular constrictions might 
be responsible for size-fractionation (Geuze et al., 1987), Figure 1.4 B. However, 
current thinking is that many ligands remain bound until late in the endocytic 
pathway, and that acidification may serve another purpose, such as in vesicle 
targeting from the early endosome (Johnson etal., 1993).
Vesicles budding from the ‘sorting endosome’ are either recycled via ‘recycling 
endosomes’ (Figure 1.4 C). These are slightly more tubular than sorting 
endosomes, have a slightly more alkaline pH and contain material not destined for 
degradation, e.g. a-2 macroglobulin (Yamashiro et al., 1984). Material destined 
for degradation is segregated into endosomal carrier vesicles (ECVs), Figure 1.4 
D, (Gruenberg et al., 1989), which require an active V-ATPase (Clague et al., 
1994), and commit their contents to degradation by their being unable to fuse with 
early endosomes (Gruenberg etal., 1989).
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1.2.2.2.2 Degradation of growth factor receptors
As well as driving the recruitment of clathrin-binding protein complexes, the 
activated kinase domain also targets the receptor for degradation inside the cell. 
(Felder et al., 1990). This is presumably to avoid the futile cycling of loaded 
receptors back to the cell surface, and maybe to increase the efficiency of 
downregulation. The ECVs fuse with acidic (pH 5.5) late endosomes, which in 
turn mature to form lysosomes (Figure 1.4 E). These have a pH of around 5.0 
(Murphy et al., 1984), which causes dissociation of all ligands from their receptors 
and activates the lytic enzymes in the vacuole. (Their low isoelectric point is 
required to prevent autolysis during synthesis or in the event of lysosome rupture.)
Clathrin-coated
vesicles
Recycling
endosomes ^  Early 
endosomes
Sorting endosome
Endosomal 
carrier vesicles
Lysosome
y  Late 
endosomes
Figure 1.4 Receptor mediated endocytosis of growth factor receptors
Growth factor receptor binding triggers a signalling cascade through its receptor, which is then 
recruited into clathrin-coated pits and internalised by endocytosis. The receptor is either recycled to 
the cell surface, or degraded in lysosomes, the decreasing pH of the lytic pathway represented by 
shading.
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1.2.2.3 The vacuolar ATPase is required for receptor mediated endocytosis
As well as dissociating ligands and activating lysosomal enzymes, the acidic pH 
generated by the V-ATPase is required for correct vesicle trafficking along the 
endocytic pathway. Bafilomycin A ,^ a specific V-ATPase inhibitor, not only 
inhibited degradation of EGF in the lysosome (Yoshimori etal., 1991), but reduced 
the delivery of a number of proteins to this compartment (van Deurs et al., 1996; 
van Weert et al., 1995). V-ATPase inhibition also inhibited the recycling pathway 
as well as the formation and fusion of acidic endosomes (Clague et al., 1994; 
Yamamoto et al., 1998), consistent with suggestions by (Johnson et al., 1993). 
They observed that bafilomycin Ai only affected the exocytosis of EGF receptors 
possessing a wild-type internalisation domain and suggested that the pH of these 
compartments regulates vesicle trafficking via effects on the conserved ‘tyrosine 
|3-turn’ motif in the internalisation domain of internalised molecules. In support of 
this, the membrane binding of the protein which initiates vesicle formation in the 
Golgi, (ADP ribosylation factor) has been shown to be dependent upon upon this 
low internal pH (Zeuzem etal., 1992).
In summary, the binding of a growth factor to its receptor causes a conformational 
change that not only starts a signalling cascade, but causes the recruitment of 
clathrin-binding proteins to the receptor, resulting in its eventual endocytosis. 
Internalised receptors are sorted in the early endosomal compartments, with 
activated receptors being targeted for degradation rather than recycling. The V- 
ATPase progressively acidifies the vesicular environment, mediating vesicle 
targeting, and terminating signalling by the receptor by causing ligand dissociation; 
the low pH eventually activating enzymes that degrade the receptor.
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This disruption of the endocytic pathway through direct inhibition of the V-ATPase 
illustrates its pivotal role in downregulation of activated growth factor receptors. 
The effects of V-ATPase inhibition are similar to those observed in E5-expressing 
cells (Straight et al., 1993; Waters et al., 1992). This suggests a common 
mechanism of transformation by the E5 proteins through binding to ductin and 
inhibiting the V-ATPase.
1.3 The vacuolar proton-translocating adenosine 5’ trisphosphatase 
(V-ATPase)
The search for the vacuolar ATPase (V-ATPase) was started by the discovery of a 
novel potassium excretion mechanism in insect epithelia (Ramsay, 1953). In 
contrast to the Na+/K+ antiporter, this was not inhibited by ouabain and vanadate, 
and despite its inhibition by the mitochondrial (F-type) ATPase inhibitor, N’N- 
dicyclohexidecarbodiimide (DCCD), it was not affected by other F-ATPase 
inhibitors, such as sodium azide and oligomycin, (Wieczorek et al., 1986). These 
properties defined a new type of proton pump being discovered in chromaffin 
granules (Kirshner, 1962), lysosomes (Schneider, 1979) and clathrin-coated 
vesicles (Stone et al., 1983). In all cases it functioned as an ATP-driven proton 
pump, but its eventual role depended upon its cellular location. The various 
activities will be dealt with briefly here, but for reviews see (Harvey and Wieczorek, 
1997) and (Wieczorek et al., 1999a).
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1.3.1 Intracellular pH regulation
Proton transport creates a proton gradient across the membrane, which in turn 
creates a potential difference. If chloride channels are present in the membrane, 
this potential difference can drive the co-transport of chloride ions, forming 
hydrochloric acid and generating a transmembrane pH gradient. V-ATPases 
have been detected in the plasma membrane of some cells, and this has been 
proposed as a mechanism of intracellular pH regulation in corneal cells and 
macrophages (Swallow et al., 1990; Torres-Zamorano et al., 1992). This is 
possibly required to compensate for lactate production in the anaerobic 
environment of the corneal epithelium and the high level of lysosomal acidification 
in macrophages. The importance of regulating cytoplasmic pH is highlighted by 
the discovery that a plasma membrane V-ATPase in cardjomyocytes protects 
against myocardial infarction by attenuating cytoplasmic acidification that would 
otherwise lead to apoptosis (Gottlieb etal., 1996).
1.3.2 Extracellular pH regulation
i
Extracellular pH regulation is crucial for many tissues. In kidney tubules, it 
ultimately regulates the pH of the blood (Gluck et al., 1982), and in the lumen of 
the epididymis, the low pH is required for sperm maturation and as such, the V- 
ATPase has been suggested as a target for modulating fertility (Breton et al., 
1996). Low pH is used by osteoclasts to dissolve bone matrix (Sasaki et al., 1994) 
and in a similar manner by ameloblasts to dissolve tooth enamel, although the pH 
was suggested to activate lytic enzymes rather than directly solubilising the
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inorganic substrate (Lin et al., 1994). Chondrocytes are also thought to use acidic 
pH to denature collagen prior to digestion (Creemers etal., 1998).
1.3.3 Active transport
In mammalian cells, the combination of the Na+/K+ plasma membrane ATPase 
and the K+ channel generates a sufficient electrochemical gradient to drive most 
transport processes, e.g. glucose via the Na+/glucose symporter (Hediger and 
Rhoads, 1994). Despite only one occurrence of V-ATPase-driven plasma 
membrane energisation in mammals (Simon et al., 1992), there are examples in 
other animals: sodium uptake in frog skin (Lacoste et al., 1993), and V-ATPase 
induced alkalinlsation of the Tobacco hornworm midgut by proton-motivated active 
transport of potassium ions (Wieczorek etal., 1991).
Inside the cell, the V-ATPase drives a number of other active transport processes. 
These range from activities secondary to their endosomal locations, e.g. 
osmoregulation and amino acid accumulation in plant vacuoles (Sze et al., 1992), 
to dedicated roles such as in neurotransmitter accumulation. (Kirshner, 1962). 
Interestingly, the method of transport depends on the type of neurotransmitter, 
both the pH gradient and the electrochemical gradient being used to transport 
catecholamines (Njus et al., 1986) but only the electrochemical gradient being 
used to transport glutamate (Cidon and Sihra, 1989). In all cases, it is the 
‘context’ of the enzyme in the cell that defines its function; the enzyme itself 
always acts as an ATP-driven proton pump.
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1.3.4 Structure of the V-ATPase
1.3.4.1 The structure of the V-ATPase is similar to bacterial ATPases
When V-ATPases were first observed by electron microscopy (Gupta and 
Berridge, 1966) the projections from the membrane surface were reminiscent of 
'ball and stick' structures seen on mitochondrial inner membranes. Subsequent 
structural analysis confirmed this similarity with the ATP synthase (F-ATPase) 
(Bowman et al., 1989) and genetic analyses revealed varying degrees of 
sequence identity between F-type and V-type subunits (Mandel et al., 1988; 
Zimniak et al., 1988). The F-ATPase has been studied more extensively, but the 
similarities between the two enzymes has led to structural and mechanistic 
predictions of the V-ATPase based on the working models of the F-ATPase.
The biochemistry of the F-ATPase has been reviewed (Boyer, 1997), describing 
how the enzyme consists of a membrane-bound proton-translocating ‘Fo’ 
complex, coupled by ‘stalk’ subunits to the hydrophilic ‘Fi’ ATP-synthesising 
complex (Figure 1.5). This structure has since been partially resolved by 
crystallisation of the whole enzyme (Stock et al., 1999), showing that the Fo 
consists of a ring of 10-12 (Jones et al., 1994) small proton-conducting 
proteolipids (subunit c) coupled to six large ATP-binding proteins (subunits a and 
P) in the Fi. In addition to structural information on the enzyme, studies on the 
sub-components of the enzyme have revealed aspects of the catalytic 
mechanism.
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Structural analyses of subunit c by Nuclear Magnetic Resonance (Rastogi and 
Girvin, 1999), have shown that the deprotonation of the active glutamic residue 
causes a conformational change capable of driving the rotation of the y subunit. 
This rotation has been correlated to conformational changes in the catalytic p 
subunits, which are in turn related to the nature of their bound nucleotide 
(Abrahams et al., 1994), Figure 1.5, demonstrating a means of coupling the 
proton-driven rotation of the Fo-associated stalk to catalysis in the Fi. By fusing 
actin to the y subunit it was even possible to observe rotation in response to ATP 
addition (Noji et al., 1997). This has also been shown for another component of 
the stalk complex, the e subunit (Kato-Yamada et al., 1998), and also for subunit c 
(Sambongi et al., 1999), suggesting that the stalk and subunit c arrangement act 
as the rotor in the proposed scheme of rotational catalysis (Figure 1.5).
This rotational model for catalysis by the F-ATPase can be extended to the V- 
ATPase in light of similarities between the two enzymes. Further evidence for the 
evolution of the V-ATPase from the F-ATPase comes from the discovery of two 
‘intermediate’ forms of enzyme which share characteristics of both types; the 
prokaryotic V-type sodium-translocating ATPase (Na+-ATPase) from 
Enterococcus hlrae and the archaebacterial proton-translocation ATPase (A- 
ATPase).
The Na+-ATPase was discovered as an ATP-driven sodium pump in 
Streptococcus faecalis (Heefner and Harold, 1980) and later in E. hlrae (Kakinuma 
and Igarashi, 1989). Sensitivity to nitrate and N-ethyl maleimide (NEM) suggested 
its similarity to the V-ATPase (Kakinuma and Igarashi, 1990), which was 
supported by sequence comparisons of the enzyme subunits revealing 15-50%
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sequence identity to subunits of the S. cerevisiae V-ATPase (Takase et al., 1994). 
In addition the enzyme was found to contain a 16kDa proteolipid similar to ductin, 
with an active glutamic acid, as opposed to the 8kDa protein bearing the aspartic 
acid seen in the F-ATPase (Kakinuma et al., 1993; Takase et al., 1999). 
However, the enzyme did not posses the regulatory cysteine found in the V- 
ATPase subunit A (section 1.3.5.2.1) and was insensitive to inhibition by 
bafilomycin Ai and concanamycin A, reviewed by Kakinuma et al., (1999), 
demonstrating its similarity to the F-ATPase.
The archaebacterial A-ATPases are ATP synthases with structural features of V- 
ATPases. Their properties vary between organisms and have been reviewed by 
Muller et al., (1999). Of greatest interest is the observation that A-ATPases 
possess many subunits not seen in F-ATPases (Schafer and Meyering-Vos,
1992), and that some species express duplicate or triplicate forms of the 8kDa 
proton-translocating proteolipid (Muller et al., 1999; Ruppert et al., 1999), 
suggesting mechanisms for the origin of the duplicate form (ductin) seen in the V- 
ATPase. In contrast to the V-ATPase, which has 6 active acidic residues in the 
proteolipid complex the A-ATPase maintains at least 8 and usually 12 (Muller et 
al., 1999; Ruppert et al., 1999) and is also distinct in that it is capable of 
performing ATP synthesis. This led to the suggestion that the restriction of the V- 
ATPase to proton pumping is due to the number of acidic residues per enzyme, 
rather than the size of the proteolipid (Ruppert et al., 1999), and is discussed 
further in section 1.3.5.3.4.
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Figure 1.5 Tertiary structure of the F-ATPase
The enzyme uses the potential energy of a transmembrane proton gradient to drive ATP synthesis. 
Proton translocation through the membrane-bound proton-translocating ‘Fo’ complex drives the 
rotation of the y subunit, which sequentially changes the conformation of the catalytic F1 subunits, 
driving ATP synthesis. Adapted from (Boyer, 1999).
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ATP
Vphlp
c (ductir)
Figure 1.6 Subunit organisation of the V-ATPase
ATP-hydrolysis in the V1 sector drives proton translocation by Vo sector by the same rotor-stator 
scheme of catalysis as seen in the F-ATPase. However, the V-ATPase contains additional subunits 
and cannot reverse its action to synthesise ATP.
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Table 1.1 Properties of the S. cerevisiae V-ATPase subunits
The location of the subunits in the V-ATPase is indicated along with their molecular mass, 
suggested F-ATPase homologue, and function in the enzyme. Adapted from Finbow and Harrison, 
(1997).
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1.3.5 Gross structure
Figure 1.6 shows the proposed structure of the V-ATPase. In line with the ball 
and stick structures seen by electron microscopy, the enzyme is believed to follow 
the pattern of F-ATPases (Pedersen and Amzel, 1993). A hydrophilic catalytic 
head complex, termed Vi associates with the proton-conducting membrane-bound 
complex, termed Vo. However, the V-ATPase has more subunits, and areas of 
poor sequence homology between the two types leaves gaps in the allocation of 
homologues. In fact, only subunits A, B, D and c (ductin) show notable homology 
with F-ATPase subunits.
1.3.5.1 Subunit structure and function
The yeast V-ATPase is the best characterised form, and will be considered here. 
Genome sequencing programmes have revealed homologous V-ATPase genes in 
a number of organisms (Manolson etal., 1988; Nishigori etal., 1998) suggesting a 
similar conservation of structure and function. The information on the yeast V- 
ATPase subunits is summarised in Table 1.1.
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1.3.5.2 Catalytic Vi sector
1.3.5.2.1 Subunit A
This is the homologue of the F-ATPase (3 subunit, showing 25% protein sequence 
homology (Bowman et al., 1988b). Protection studies identified the presence of 
the suggested ATP hydrolysis site by using ATP analogs azido-ATP and 7-chloro- 
4-nitrobenzo-2-oxa-1,3-diazole chloride which inhibit the enzyme and label subunit 
A in an ATP-protectable manner (Arai etal., 1987b; Uchida etal., 1988a; Zhang et 
al., 1995). The sulphydryl reagents, N-ethyl maleimide (NEM) and omeprazole 
behave identically despite their non-resemblance to ATP (Arai et al., 1987b; 
Nadler et al., 1998), which led to the discovery of a regulatory cysteine (C254) at 
the ATP binding site (Feng and Forgac, 1992). In the V-ATPase, C254 is the 'X' in 
the conserved GXGKTV Walker consensus ‘A’ sequence identified as the 
nucleotide-binding 'p-loop' (Walker et al., 1985), and is thought to allow regulation 
of the V-ATPase in response to the REDOX state of the cell by disulphide bond 
formation with cysteine-532, as discussed in section 1.3.6.4.
1.3.5.2.2 Subunit B
This has 25% homology with subunit A, and with the regulatory a subunit of the F- 
type enzyme (Manolson et al., 1988). It also contains the p-loop sequence 
(Nelson et al., 1989) and labels with ATP-analogs (Manolson et al., 1985). 
However, from structural information inferred from the F-ATPase a-subunit 
(Abrahams et al., 1994) and demonstrations of the resistance of enzyme activity to
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mutations of the ATP binding site of this subunit (Liu et al., 1996), it is thought that 
subunit B is responsible for allosterically regulating the activity of the enzyme in 
response to ATP (Arai et al., 1989).
1.3.5.2.3 Subunit C
Not to be confused with the proteolipid, subunit c, the precise function of this 
subunit is unknown. It has no homology with any subunit from the F-ATPase, but 
studies in Saccharomyces cerevisiae suggest it may play a role in Vi assembly 
(Beltran et al., 1992; Ho et al., 1993a). However, it is not always seen in 
preparations from Neurospora crassa (Bowman et al., 1992) and the form seen 
isolated from bovine clathrin-coated vesicles does not seem to be essential for 
activity (Puopolo et al., 1992b). Interestingly, despite poor sequence 
conservation, the yeast V-ATPase can tolerate extensive bovine subunit C 
chimeras (Beltran et al., 1992), so it seems that the structure rather than the 
sequence may well be conserved. Further characterisation of this subunit will be 
useful in highlighting the differences between the F- and V-type ATPases.
1.3.5.2.4 Subunit D
This has only weak homology with an F-ATPase subunit; the y-subunit, which acts 
as the central spindle coupling the Fi and Fo (Nelson et al., 1995). There is no 
firm evidence to suggest that it performs this role in the V-ATPase, since it is 
dispensable in the bovine enzyme (Crider etal., 1997) and only weakly associated 
in N. crassa (Margolles-Clark et al., 1999). However its isoelectric point is similar
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to the y-subunit of the F-ATPase, and the conservation is concentrated around 
areas implied to interact with A-B subunit complex involved in rotation (Nelson et 
al., 1995).
1.3.5.2.5 Subunit E
This also has a similar size and structure prediction to the y-subunit (Bowman et 
al., 1995). It has no homology to any other protein but its pattern of conservation 
across species closely matches that of the y-subunit (Margolles-Clark et al., 1999) 
suggesting that, assuming the two have similar structures, their functional 
domains are in the same place. Unlike subunit D, subunit E is indispensable for 
bovine V-ATPase function (Crider etal., 1997) and remains tightly associated with 
the N. crassa enzyme, although its isoelectric point is 3 units lower than that of the 
y-subunit. One suggestion is that the stalk is composed of both subunits D and E 
(Tomashek et al., 1996), which may also account for the extra length of the V- 
ATPase stalk (Dschida and Bowman, 1992).
1.3.5.2.6 Subunit F
This has no significant homology to any of the proteins in the F-ATPase.
However, its size and isoelectric point are very similar to that of the e-subunit of E.
coli F-ATPase and the o-subunit of the mitochondrial F-ATPase (Nelson et al.,
1994), which themselves are poorly conserved over species (Walker et al., 1985).
On these grounds it was suggested to be the V-ATPase counterpart of these
subunits, linking the Vo sector to the stalk (Nelson et al., 1994). Interestingly, this
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study also demonstrated that addition of antibodies to subunit F caused inhibition 
whilst retaining coupling, indicating that it may be involved in regulating activity. 
Helical wheel projection identified a distinct region of sequence conservation, 
which along with the high content of charged residues suggested a bridging 
function for the protein.
1.3.5.2.7 Subunit G
Despite exhibiting homology to the F-ATPase Fo subunit b, this subunit has no 
predicted transmembrane domain (Supekova et al., 1996). Its designation as part 
of the Vi, on the basis of cold-induced dissociation from the membrane in 
Manduca sexta (Lepier et al., 1996) is contradicted by its retention to the Vo in 
yeast (Supekova et a i, 1995). Because the V-ATPase is a two-part enzyme, 
fickleness of the proteins at the interface is not unexpected, supporting the theory 
that subunit G performs the same role as subunit b, anchoring the catalytic 
complex to the membrane complex to form the stator. The findings that helical 
wheel projections show high conservation on one face of the helix (Hunt and
i
Bowman, 1997) and that it contains a high proportion of charged residues are 
consistent with it performing a bridging function.
1.3.5.2.8 Subunit H
This has no homology to other proteins, and has no counterpart in the A- and F- 
ATPases. The yeast protein and nucleic acid sequences fail to find matches in the 
Genbank database despite the discovery of proteins of similar mass in plant and
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bovine material (Parry et al., 1989; Puopolo etal., 1992b). Despite its requirement 
for yeast growth at neutral pH (Ho et al., 1993b) it was found to be involved in 
enzyme stability rather than assembly (Puopolo etal., 1992b).
1.3.5.3 The Vo sector
1.3.5.3.1 Vma12p, Vma21 p and Vma22p
These proteins are responsible for guiding the assembly of the Vo sector rather 
than being active components of the final V-ATPase complex. Vma12p is 
predicted to be a two-pass transmembrane protein in the endoplasmic reticulum 
(ER) required for Vph1 stability and correct Vo assembly and targeting to the 
vacuole (Hirata et al,, 1993; Jackson and Stevens, 1997). Vma22p is similar in 
many ways in that it is an ER resident protein that prevents Vphlp degradation in 
the ER and is required for assembly of the V-ATPase (Hill and Stevens, 1995). 
Although Vma22p is a hydrophilic protein, it is associated to the membrane via its 
interaction with Vma12p (Graham et al., 1998), this complex also interacting with 
Vphlp, and so being implicated in chaperoning its assembly into the Vo (Graham 
etal., 1998).
Vma21p is not found in the Vma12/22p complex (Graham et al., 1998). It is 
similar to Vma12p in that it is a small ER-resident protein with two predicted 
transmembrane domains that is required for Vphlp stability (Hill and Stevens,
1995). However, its exact function is not known; it was suggested that it might be 
a part of the Vma12/22p complex or that it may even be involved in regulating 
vesicle trafficking of the V-ATPase to the vacuole (Graham and Stevens, 1999).
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1.3.5.3.2 Vph1p/Stv1p
Two complementary genes code for this protein in yeast; VPH1 and STV1 (Similar 
To VPH1) resulting in an incomplete vacuolar disruption (Manolson et al., 1992). 
The reason for this is not known, but STV1 is expressed at lower levels than 
Vphlp, to which it is only 55% identical and may contain Golgi retention signals. 
Suggesting that the two are location-specific isoforms (Manolson et al., 1994). 
Both proteins are predicted to be 6-7 pass transmembrane glycoproteins (Adachi 
et al., 1990; Manolson et al., 1992), required for assembly of the Vo complex 
(Kane et al., 1992), mutational studies attributing this function to the carboxy 
terminus (Leng et al., 1998). The presence of crucial charged residues in the 
transmembrane domains (Leng et al., 1998; Leng et al., 1996) and a bafilomycin 
Ai binding site (Bowman et aL, 1988a) suggest a role for these proteins in proton 
translocation, consistent with the proposed role of their homologue (subunit a) in 
the F-ATPase (Jiang and Fillingame, 1998).
1.3.5.3.3 Subunit d
Unlike the other Vo subunits, this subunit can be stripped from the membrane by 
strong chaotropic agents (Bauerle et al., 1993), which along its hydrophilicity and 
lack of any putative transmembrane domains, suggests that it is associated to, 
rather than integrated into the membrane. Its absence destabilises the Vo, 
preventing the Vi from docking (Bauerle et al., 1993), but its role aside from being 
an assembly factor has not been probed.
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1.3.5.3.4 Subunit c (ductin), and related proteins
Ductin is the 16kDa protein found in preparations of gap junctions, mediatophores 
and V-ATPases (Brochier and Morel, 1993; Finbow et al., 1983; Mandel et al., 
1988); its role as a channel protein leading to it being called ductin (duct protein) 
(Holzenburg et al., 1993). Its multifunctional nature is illustrated by the ability of 
Nephrops norvegicus ductin, discovered in gap junction preparations, to 
complement the function of S. cerevisiae ductin in the V-ATPase (Harrison et al.,
1994). One of the reasons it is capable of forming so many structures is that it is 
inserted into the lipid bilayer in both orientations (Dunlop et al., 1995); the 
environment of the hydrophilic loops determining the binding activity and eventual 
function, reviewed by Finbow et al., (1995). The number of functions (and hence 
the number of residues susceptible to mutation) may also explain why ductin is the 
most conserved integral membrane protein known, with 65% sequence 
conservation between all species.
Structural predictions, and sequence comparisons with the F-ATPase subunit c 
suggested that ductin forms a 4-pass a-helical bundle, with an active glutamic 
acidic residue in the middle of the fourth helix, reminiscent of a dimeric form of 
the subunit c (Figure 1.7), (Finbow et al., 1992). Further sequence comparisons 
between the two proteins suggested that they evolved from a common ancestor, 
with gene duplication accounting for their size differences (Figure 1.8), (Mandel et 
al., 1988). This was supported by the finding that the E. coli subunit c can be 
functionally substituted by a dimeric or trimeric construct of the protein (Jones and 
Fillingame, 1998), however, the V-ATPase cannot synthesise ATP, so it was 
suggested that the number of active acidic residues per enzyme determines the
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type of activity (section 1.3.4.1), (Cross and Taiz, 1990; Ruppert et al., 1999). 
This would agree with the thermodynamic differences between the two enzymes, 
with the ratio of ATP to proton binding sites corresponding to a high 
substrate:product ratio in both enzymes, which would be expected to increase 
their processivity of the enzymes by increasing the equilibrium constant.
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Figure 1.7 Membrane disposition of ductin and organisation in the Vo
Membrane disposition of Nephrops norvegicus ductin, adapted from (Finbow et al., 1995), showing 
the transmembrane location of the active glutamic acid and the disposition in the membrane, with 
loops 1 and 3 believed to be apposed in gap junctions, and face the V1 portion of the V-ATPase 
consistent with the dual orientation of ductin. The arrangement of the four helices in the Vo is 
shown as determined by cysteine mutagenesis crosslinking experiments (Harrison et al., 1999). 
The active glutamic acid residue is indicated by an asterisk and is situated on the exterior face of 
the complex, analogous to the aspartate in subunit c of the F-ATPase (Girvin et al., 1998).
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Figure 1.8 Proposed evolution of ductin and related proteolipids
Transmembrane domains are indicated by rectangles, critical acidic residues by asterisks, adapted 
from Finbow and Harrison, (1997). The sequence similarities between the proteins indicate their 
similar roles in the F-, A-, and V-ATPases, however, the function of TFP3 is not known. VMA16 is 
thought to be involved in proton translocation, but has an additional transmembrane domain, and a 
different placement of its critical glutamate. The functional significance of VMA11 is also unknown 
since it has only been discovered in fungal sources (Lyne et al., 1999; Pounder and Bowman, 1999; 
Umemoto et al., 1991).
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The active glutamate is specifically labelled by N’N-dicyclohexidecarbodiimide 
(DCCD) (Arai et al., 1987a; Finbow et al., 1992), a reagent which labels acidic 
residues in non-polar environments. This labelling corresponded with inhibition of 
the enzyme, showing that the residue is not only exposed to the lipid bilayer, but is 
implicated in catalysis. The lipid-exposure of the glutamate was confirmed by 
structural analysis employing cysteine mutagenesis and N-(1-pyrenyl)maleimide 
labelling to identify proximal and lipid-exposed residues respectively (Harrison et 
al., 1999). This study also revealed similarities to the structure of the F-ATPase 
subunit c (Jones et al., 1998), with even numbered helices forming the exterior 
face, as shown in Figure 1.7.
Proton permeability assays on vesicles containing reconstituted Vo sectors 
confirmed the role of ductin, with it alone being able to form a proton channel for 
the V-ATPase, and the other Vo subunits merely enhancing the permeability 
(Zhang et al., 1994). This contradicted previous results showing that the Vo does 
not act as a pore for passive proton diffusion (Zhang et al., 1992). The reasons 
for this are not known, but it was suggested that although ductin is capable of 
forming a proton channel In vitro, its permeability depends upon other factors 
(Zhang et al., 1994). From these results it was thought that the ductin was the 
only proton-conducting component of the V-ATPase, however, other related 
proteolipids have since been discovered, Vma11p and Vma16p (Figure 1.8) which 
are related to ductin which may be involved in proton translocation (Apperson et 
al., 1990; Hirataefa/., 1997; Umemoto et al., 1991).
Vma11 p also called subunit c’ is the same size as, and has 54% sequence identity 
to ductin (Umemoto et al., 1991). Although only a minor component of the Vo
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(Hirata et al., 1997), gene inactivation resulted in significant loss of V-ATPase 
activity (Umemoto et al., 1991), and like ductin its function is also dependent upon 
a glutamic acid in the fourth transmembrane domain (Hirata et al., 1997). The 
VMA11 gene knockout can be partially rescued by overexpression of ductin (M. 
Harrison, unpublished observations), however any single helix replacements of 
Vma11p to those of ductin ablate the activity of the V-ATPase, (A. Ashby, 
unpublished results) so it does appear to have a distinct function. Interestingly, 
Vma11p has only been discovered in fungal V-ATPases (Lyne et al., 1999; 
Pounder and Bowman, 1999; Umemoto et al., 1991) so it may represent a 
functional adaptation specific for these organisms.
Vma16p, also called subunit c” has only 35% homology to ductin and 30% cross 
species identity, it having been identified in Arabldopsls, Caenorhabditls, yeast, 
human and mouse. Again, inactivation of the VMA16 gene disrupts vacuolar 
function, suggesting that it is an essential component of the V-ATPase 
Structurally, it is thought to be very similar to ductin with the exception that has an 
extended N-terminus and retains a glutamic acid in its second helix rather than the 
fourth (Figure 1.8) (Apperson et al., 1990). Despite this similarity, Vma16p does 
not bind to BPV-4 E8 (Faccini et al., 1996), and it appears that the glutamic acid 
on the second helix is involved in proton translocation rather than that on the 
fourth (Hirata et al., 1997), a finding supported by the relatively high level of 
conservation in this helix across species. The N-terminal extension is predicted to 
be a transmembrane a-helix, but although it is required for activity, its purpose is 
not known. It might be that it occludes the pore in the middle of the Vo 
(Cadwallader and Finbow, unpublished results), and perhaps explains the
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differences in permeabilities between different Vo preparations (Zhang et al., 
1994; Zhang etal., 1992).
The function of Tfp3p, so named because its overexpression confers resistance to 
trifluorperazine in yeast (Shih et al., 1990), remains elusive. It has not been 
identified as a formal V-ATPase subunit, so it is likely that despite its homology to 
ductin, it has a separate function, perhaps as another type of membrane channel.
1.3.5.4 Summary
The parallels between the V-ATPase and the F-ATPase allow information to be 
inferred about the catalytic mechanism, however, the V-ATPase has additional 
subunits, different patterns of sequence conservation, and a different pattern of 
inhibitor sensitivity than the F-ATPase (Bowman, 1983; Drose and Altendorf, 
1997; Uchida et al., 1988b), suggesting that there are fundamental differences 
between the two types. One way in which this manifests itself is through the 
differences in the ways the enzymes are regulated; an unsurprising feature since 
the enzymes effectively perform opposite roles and operate in different cellular 
locations, albeit using the same blueprint for catalysis.
1.3.6 Regulation of the V- ATPase
The activity of the V-ATPase needs to be regulated around the ATP budget of the 
cell and also to meet the specific demands of the compartment upon which it 
resides. For example, early endosomes require only a slight pH gradient
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compared to lysosomes (Gruenberg and Maxfield, 1995). To this end, the 
enzyme is regulated at many stages within the cell, the effects varying in timescale 
and consequence.
1.3.6.1 Transcriptional regulation
Neurospora crassa V-ATPase gene promoters are thought to resemble 
consititutively-expressed housekeeping genes (Wechser and Bowman, 1995), but 
observations of cyclic adenosine monophosphate (cAMP)-dependent upregulation 
of subunit B expression during monocyte to macrophage differentiation (Lee etal.,
1995), suggest that the situation may be different in higher organisms. Studies on 
Manduca sexta subunits reviewed by Wieczorek et al., (1999b) support this claim, 
with both V-\ and Vo subunits possessing upstream ecdysone response elements 
and exhibiting ecdysone-induced downregulation. Vi subunit sequences also 
contain what appear to be cAMP-responsive elements and are upregulated in 
response to cAMP (Merzendorfer, 1998). This differential regulation of the Vi and 
Vo subunits is probably related to the fact that the two halves of the enzyme are 
often present in different amount in the cell (Myers and Forgac, 1993a).
1.3.6.2 mRNA stability
The role of the 3' untranslated region (3'-UTR) in mRNA stability is reviewed by 
Decker and Parker, (1994). cDNA sequencing has revealed variation in the 
sequences of 3' untranslated regions of Vo and \/  ^ subunits (Dow et al., 1992; 
Graf et al., 1994), coupled with differential expression in one case (Puopolo et al.,
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1992a). Unpublished results reviewed by Merzendorfer et al., (1997a) support this 
suggestion by the observation of size differences in transcripts of M. sexta subunit 
B corresponding to two different polyadenylation sites. The discovery of signal 
recognition particle (SRP) independent localisation of ductin mRNA also led to the 
suggestion that the 3' untranslated regions were involved in subcellular targeting 
(Jager e ta i, 1996).
Regulation by way of antisense RNA transcription has also been suggested, 
reviewed by Knee and Murphy, (1997). It is thought that formation of double 
stranded RNA renders the transcript vulnerable to degradation by double-stranded 
ribonucleases. Evidence for this type of regulation for the V-ATPase comes from 
the identification of antisense transcripts of the M. sexta M40 subunit by reverse 
transcriptase polymerase chain reaction (RT-PCR) (Merzendorfer et al., 1997b) 
but whether this is significant, or even whether antisense regulation actually 
occurs in eukaryotes has yet to be proven.
1.3.6.3 Protein Targeting
The AP-2 adapter protein complex, responsible for recruiting EGF receptors to
clathrin-coated pits is also implicated in activation of the V-ATPase. The 50kDa
subunit of the AP-2 complex was found to associate with the V-ATPase and
phosphorylate subunit B (Myers and Forgac, 1993b). These results were
expanded upon by the finding that this 50kDa subunit is actually required for
activity and assembly of the enzyme (Liu et al., 1994). The interrelationship
between endocytosis and the V-ATPase makes this mechanism of regulation
attractive, since it ensures an even number of V-ATPases per internalised vesicle.
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1.3.6.4 Cytoplasmic REDOX conditions
The role of the conserved cysteine residue at the catalytic site in regulating 
enzyme activity in response to REDOX conditions has been discussed in section 
1.3.5.2.1. As well as inhibition and specific labelling by sulphydryl reagents there 
are genetic data to show that this is more than just a casual feature of the 
enzyme.
CYS4 encodes cystathione p-synthase, a key enzyme in cysteine and subsequent 
glutathione synthesis, but a CYS4 mutant has also been shown to disrupt the V- 
ATPase (Oluwatosin and Kane, 1997), implicating either the enzyme itself, the 
cellular levels of cysteine, or its downstream products in the regulation of the V- 
ATPase. Addition of glutathione to the medium restored activity, so it was 
suggested that the phenotype was due to oxidation of the regulatory cysteine in 
subunit A rather than any mistranslation effects due to cysteine starvation 
(mutation of certain cysteine residues in subunit A also result in loss of activity 
(Taiz et al., 1994)). This idea was reinforced by the finding that mutation of the 
regulatory cysteine in subunit A renders the enzyme insensitive to the effects of 
CYS4 mutation and glutathione (Oluwatosin and Kane, 1997).
Glutathione is produced by reduction of oxidised glutathione by reduced 
nictotinamide adenine dinucleotide phosphate (NADPH), which is also 
interconverted to reduced nictotinamide adenine dinucleotide (NADH), which is 
the substrate for ATP synthesis in mitochondria. So it might be that the oxidative 
inhibition of the V-ATPase is actually an NADH detection mechanism to avoid cell 
starvation. This cysteine-mediated REDOX regulation not only accounts for the
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differences in the sensitivity of the two enzymes to NEM (section 1.3.5.2.1), but 
highlights one of the differences between the F and V type ATPases which fits 
well with their function. The F-ATPase is part of a system originally devised to 
allow prokaryotes to tolerate oxidative stress, so oxidative inhibition would be 
counterproductive. V-ATPase activity on the other hand appears to be controlled 
to ensure that the cell has sufficient ATP, by using disulphide bridge-mediated 
inhibition to detect NADH levels indirectly.
1.3.6.5 Nutrient availability
The V-ATPase is responsible for 10% of the total ATP consumption in M. sexta 
larva (Dow, 1984) so REDOX monitoring as a method of verifying the potential of 
the cell to generate ATP is not unexpected. However there is another mechanism 
of regulation that is more directly linked to verifying the potential of the cell to 
make ATP; regulation in response to glucose concentrations.
Starvation-induced dissociation of the V-ATPase was first demonstrated in M.
sexta, (Sumner et al., 1995), from discovering a 90% loss of V-ATPase activity
and an absence of /^^  subunits in membrane preparations from moulting larvae.
Consistent with these observations, the dissociated /^^  complex was purified from
the cytoplasm and shown to have negligible Mg-ATPase activity (Graf et al.,
1996). This starvation response was also demonstrated in yeast (Kane, 1995), a
more thorough investigation showing that this occurred independently of all known
glucose-signalling pathways and was not dependent upon ATP levels (Parra and
Kane, 1998). However, dissociation did require ATP hydrolysis since dissociation
was inhibited by concanamycin A or by using ATPase-defective strains that were
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still capable of assembly (Hirata et al., 1997; Leng et al., 1996). The suggested 
reason for this regulation was to conserve ATP during starvation conditions, whilst 
permitting a rapid restoration of activity upon addition of glucose to neutralise the 
drop in cytoplasmic pH seen when glycolysis is re-started (Beauvoit et al., 1991; 
Parra and Kane, 1998).
When investigating the effects of alternative carbon sources, it was found that 
raffinose, despite its metabolism into glucose, did not induce reassembly to the 
same extent as glucose (Kane, 1995). Even cells grown in raffinose for prolonged 
periods show reduced levels of assembly (Kane, 1995), suggesting that the 
regulation is a graded rather than an absolute response.
1.3.6.6 Coupling efficiency
Despite the fact that the enzyme is designed to be as efficient as possible, there 
are cases when partial coupling is an advantage, for example in the early 
endosomal membranes where only a slight pH gradient is required. This was first 
observed in the F-ATPase (Groen et al., 1990) and was later termed 'slip' in 
reference to the V-ATPase (Nelson, 1991). The advantage of using slip regulation 
might be that it can be a rapid and highly localised effect; ideal for use in the 
endocytic vesicle pathway.
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1.3.6.7 Regulation of vacuolar pH
The chloride channel is thought to determine the balance between the 
electrochemical and pH gradient generated by the V-ATPase (Fuchs et al., 
1989a). The pH of endosomal compartments can also be regulated by the Na+/K+ 
ATPase, by way of alleviating the electrochemical gradient (Fuchs et al., 1989b); 
consistent with this idea is the absence of the Na+/K+ ATPase in late endosomes 
and lysosomes.
1.3.7 Summary
The V-ATPase is a highly regulated enzyme responsible for driving a number of 
cellular activities, including the maintenance of the endocytic pathway for 
processing cell surface receptors. Because a number of viral oncoproteins bind to 
the proteolipid component of the enzyme (Conrad etal., 1993; Faccini etal., 1996; 
Franchini etal., 1993; Goldstein and Schlegel, 1990) it is possible that its inhibition 
is implicated in their mechanism of cell transformation.
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1.4 Saccharomyces cerevisiae as a model organism to investigate the 
effects of a family of ductin-binding E5 proteins on the vacuolar ATPase
Most, if not all papillomaviruses possess and open reading frame encoding a 
small hydrophobic protein which contributes towards cell transformation and binds 
to ductin (Conrad et al., 1993; Faccini et al., 1996; Franchini et al., 1993; 
Goldstein et al., 1991). Most of the E5 proteins also bind to growth factor 
receptors (Goldstein etal., 1992a; Hwang etal., 1995; Mulloy etal., 1996), but this 
activity does always correlate with transforming potential (Nilson and DiMaio, 
1993; Sparkowski etal., 1996).
Ductin is a component of the gap junction, along with connexins. Not only are 
there a number of proteins involved in forming gap junctions, but they are also 
regulated by a number of pathways, and the role of gap junctional intercellular 
communication (GJIC) in cell transformation is unclear (see section 1.2.1). Ductin 
also forms the proton-conducting component of the vacuolar ATPase (V-ATPase), 
which acidifies the endosomal compartments that process and degrade growth 
factor receptors (section 1.2.2). Mutational analysis of BPV-1 E5 has shown that 
its ability to cause alkalinisation of the Golgi apparatus correlates with its ability to 
transform cells (Schapiro et al., 2000). Direct inhibition of the V-ATPase was not 
shown, but it did suggest that the E5 proteins transform cells through binding to 
ductin and inhibiting the enzyme. The work in this thesis investigates the effects 
of a number of E5 proteins on the V-ATPase using a system well suited to the 
study of the enzyme.
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1.4.1 Experimental rationale
V-ATPase inhibition by bafilomycin A  ^ is cytotoxic in mammalian cells in vitro 
(Ohta et al., 1998), with lower concentrations causing growth inhibition (Ohkuma 
et al., 1993). Genetic inactivation of the V-ATPase is also lethal in vivo (Davies et 
al., 1996), so an organism tolerant to V-ATPase inhibition was chosen to study the 
effects of the E5 proteins on the enzyme, Saccharomyces cerevisiae. The yeast 
V-ATPase contains at least as many subunits as the mammalian enzyme, 
suggesting similar architectures, and yeast ductin has 71% protein sequence 
identity to the bovine and human forms of ductin (92% identity in helices 3 and 4). 
In line with this conservation is the finding that BPV-1 E5 has been shown to bind 
to another form of yeast ductin; that of Schizosaccharomyces pombe (Goldstein et 
al., 1992c). Vacuolar inactivation can be tolerated by yeast if the pH of the growth 
medium is lowered to 5.5, with neutral-buffered medium providing a simple 
screening technique to assay vacuolar function. Standard protocols exist for 
genetic modification and for isolation of milligram quantities of vacuoles. In 
addition, because of the popularity of using yeast to study the V-ATPase, 
techniques have also been devised to purify the enzyme from vacuolar 
preparations, and monoclonal antibodies are available against some of the 
subunits. Another advantage is that yeast do not naturally express the growth 
factor receptors that the E5 proteins interact with, reducing the ambiguity of the 
results.
In addition to wild type E5 protein constructs, BPV-4 E8 mutant forms were also 
expressed, which all bind to ductin (Ashrafi et al., 2000) but exhibit different 
transforming abilities (O'Brien et al., 1999). These activities did not correlate with
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the disruption of one function of ductin, in gap junctional intercellular 
communication (Ashrafi etal., 2000), so their activities may be due to disruption of 
the other function of ductin, in the V-ATPase. A dominant negative form of ductin, 
previously shown to cause V-ATPase inhibition (Andresson et al., 1995) was 
included to verify the use of the yeast strain and plasmid combination to 
investigate the E5 proteins. A similar dominant negative form of ductin has also 
been shown to cause cell transformation (Andresson et al., 1995), so by 
comparing its effects to those of the E5 proteins it will be possible to see if they 
act by similar mechanisms.
To allow detection of the E5 proteins, polymerase chain reaction (PCR) was used 
to add an HA epitope tag, a short peptide derived from the HA1 haemagglutinin 
gene of the influenza virus (Field et al., 1988), which does not affect the 
transformation potential of either BPV-1 E5 or BPV-4 E8 (Andresson et al., 1995; 
O'Brien et al., 1999). In chapter 3 the use of S. cerevisiae is verified by assessing 
the binding efficacy of these epitope-tagged proteins to S. cerevisiae ductin by in 
vitro translation on microsomes followed by immunoprecipitation.
i
The E5 constructs were expressed using the pYPMA vector, (M. Harrison, Leeds 
University, UK), which was originally used to drive the overexpression of ductin 
mutants that required such high levels for detection (Jones et al., 1995). In this 
case, overexpression was used to amplify any effects of the proteins, since the 
cytotoxic effects associated with V-ATPase inhibition are not seen when the E5 
proteins are expressed in mammalian cells, suggesting that they exert subtle 
effects, if any, on the enzyme. The constructs were sequenced before
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transformation into yeast, where their correct expression in vivo was verified by a 
number of methods, the results being shown in chapter 3.
The effects of the E5 proteins were first investigated in the YPH 500 strain of 
yeast grown in glucose medium. Its auxotrophy for uracil allows pYPMA 
maintenance, whilst the ade2 mutation causes accumulation of a red pigment in 
the vacuole (Fisher, 1969), so provides an additional visual screen to that of 
growth. Chapter 4 shows the effects of the E5 proteins on growth rate, vacuolar 
acidification, V-ATPase activity and E5 binding in vivo, using the dominant 
negative form of yeast ductin as a control.
Chapter 5 shows the effects of the E5 proteins when expressed in yeast grown in 
galactose/raffinose medium. This has the effect of partially compromising the 
enzyme and possibly sensitising it to any further disruption by the E5 proteins. 
The effects in a doubly compromised system are shown in chapter 6, with the E5 
proteins being expressed in a strain of yeast transgenic for Nephrops norvegicus 
ductin, grown in galactose/raffinose medium. Nephrops ductin has been shown to 
complement the yeast ductin knockout, albeit to produce a V-ATPase with an 
elevated Michaelis constant (Harrison et al., 1994). This compromisation makes 
the transgenic system a useful model to detect any subtle effects on the V- 
ATPase. The original pTY-Nephrops ductin construct was used to minimise 
experimental variation, and because its tryptophan selection cassette is 
compatible with the leucine cassette replacing the wild type ductin, and the uracil 
selection used to maintain pYPMA.
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The data presented in this thesis show that all of the E5 proteins bind to S. 
cerevisiae and Nephrops ductin in vitro, but do not remain associated with the 
active V-ATPase in vivo, nor affect its activity. This suggests that they do not 
directly inhibit the V-ATPase, but bind to ductin for other reasons.
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2. Materials and methods
2.1 Materials
2.1.1 Equipment
Beckman (RIIC) Ltd. Oakley Court, Kingsmead business park, London road, 
High Wicombe, Buckinghamshire, HP11 1JU.
Polycarbonate centrifuge tubes
Bibby Sterlin Ltd. Tilling drive, Stone, Staffordshire, ST15 OSA
Bacteriological dishes (90mm)
Elkay Laboratory products PO BOX 6004, Basingstoke, Hampshire, RG24 
8HL
Plastic pipette tips 
Plastic tubes 
Plastic cuvettes
Invitrogen BV, PO BOX 2321, 9704 CH Groningen, The Netherlands.
NOVEX gel apparatus
Mcquilkin & Co. 21 Polmadie avenue, Glasgow, G5 OBB
12ml glass homogeniser
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2.1.2 Chemicals
Unless specified below, all chemicals were supplied by:
Fisher Scientific Ltd. Bishop Meadow Rd, Loughborough, Leics. LE11 5RG. 
or by Sigma-Aldrich Co Ltd. Fancy Road, Poole, Dorset, BH12 4QH.
3M UK, 3M House, PO BOX 1, Marketplace, Bracknell, Berkshire, RG12 1JU
Fluorinert
Anachem Ltd. Anachem House, Charles St, Luton, Bedfordshire, LU2 OBE.
Galactose
Raffinose
Becton Dickinson, Northfield Road, Botherham, South Yorkshire, S60 1RR.
BACTO peptone 
BACTO yeast extract 
BACTO agar
James Burrough (F.A.D.) Ltd. 70 Eastways Industrial Park, Witham, Essex, 
CM8 3YE.
Ethanol 99.7%
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2.1.3 Molecular biology reagents
Amersham Pharmacia . Amersham Place, Little Chalfont, Bucks, HP7 9NA.
Full and low range Rainbow molecular weight markers 
ECL Western blotting system 
Hybond ECL nitrocellulose membrane 
Promix in vitro cell labelling mix
Cambridge Bioscience Ltd. 24-25 Signet Court, Newmarket Road, 
Cambridge, CB5 8LA.
Anti AU1 monoclonal antibody 
Anti HA1 monoclonal antibody 
Anti Vma1 p monoclonal antibody 
Anti Vphlp monoclonal antibody
ICN Biochemicals Ltd. Unit 18 Thame Park business centre, Whenham Road, 
Thame, Oxfordshire, 0X9 3XA.
N-dodecyl maltoside
Yeast lytic enzyme, 70 000 units/g
Life Technologies. 3 Fountain Drive, Inchinnan Business Park, Paisley.
DH5a competent cells
DNA Restriction and modification enzymes
Low DNA Mass ladder
SOC medium
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Promega UK Ltd. Chilworth Research Centre, Southampton, S016 7NS.
Canine microsomal membranes
Nuclease treated rabbit reticulocyte lysate in vitro protein translation system
Stratagene Europe. Gebouw California, Hogehilweg 15, 1101 CB Amsterdam 
Zuidoost, Netherlands.
Dpn 1 restriction enzyme
Epicurial Coli XL10-gold ultracompetent cells
PfuTurbo DNA polymerase
2.1.4 Kits
AMS Biotechnology UK Ltd, 12 Thorney Leys Park, Witney, Oxon, 0X8 7GE.
T7 mMESSAGE mMACHINE capped RNA synthesis kit 
T7 MEGAshortscript short RNA synthesis kit 
Cap analog (m7G(5’)ppp(5’)G)
i
QIAGEN Ltd. Boundary Court, Gatwick Road, Crawley, West Sussex, RH10 2AX.
QIAprep spin miniprep kit 
QIAquick spin PCR cleanup kit
Roche Diagnostics Ltd. Lewes, East Sussex, BN7 1 LG.
Rapid ligation kit
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2.1.5 Yeast strains
W303-1BVatc MATa ura3 Iys2 ade2trp1 his3 Ieu2 vma3::LEU2
YPH 500 MATa ura3 Iys2 ade2trp1 his3 Ieu2
2.1.6 Medium composition
Luria Broth (LB) 1%w/v bacto tryptone; 0.5%w/v bacto yeast extract; 1%
NaCI, pH7.5. Heat sterilised 
Complete glucose 1 %w/v yeast extract; 2%w/v bacto peptone; 2%w/v
medium glucose. Heat sterilised
Complete As above, replacing glucose with 1%w/v galactose and
galactose/raffinose 1%w/v raffinose.
medium
Minimal glucose 
medium
Minimal galactose/ 
raffinose medium 
Minimal galactose/ 
raffinose medium 
(for Nephrops 
ductin strains)
0.67%w/v Bacto-yeast nitrogen base without amino acids; 
2%w/v glucose; 50mM sodium succinate pH5.5; 20mg/l 
adenine; 20mg/l L-tryptophan; 20mg/l histidine; 30mg/l 
leucine; 30mg/l lysine. Filter sterilised.
As above, replacing glucose with 1%w/v galactose and 
1 %w/v raffinose.
0.67%w/v Bacto-yeast nitrogen base without amino acids; 
1%w/v galactose; 1%w/v raffinose; 50mM sodium 
succinate pH5.5; 20mg/l adenine; 20mg/l histidine. Filter 
sterilised.
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2.2 Methods
2.2.1 Oligonucleotide design
BPV-1 E5, HTLV-1 p121 and HPV-16 E5 were amplified by PCR using 
oligonucleotides incorporating BamH 1 and Kpn 1 restriction sites and a HA 
epitope tag. These allowed ligation of the PCR product directly into the BamH 1 
site of the pYPMA vector, and rapid determination of orientation by Kpn 1 
restriction digestion. The epitope tag allowed detection by commercially available 
antibodies (Field et al., 1988). The sequences are shown below, with restriction 
sites in bold and the haemagglutinin epitope tag underlined. The BPV-1 E5 5’ 
oligonucleotide was shorter because the template already contained the HA1 tag.
HA BPV-1 E5 5’
GCGGGATCCATGCCAAATCTATACCCATACG 
HA BPV-1 E5 3’
GCGGGATCCGGTACCTTAAAAGGGCAGACCTGTACAG 
HA HTLV-1 p12' 5’
GGGATCCGCCGCCACCATGTACCCATACGATGTTCCAGATTACGCTCTGTTTCGCCTTCTCAGCCC
HA HTLV-1 p12' 3’
GGGATCCCGGTACCCTAGAAGAGGAAAGCCGCGG
HA HPV-16 E5 5’
GGCGGATCCTGCCGCCACCATGTACCCATACGATGTTCCAGATTACGCTACAAATCTTGATACTGCA
HA HPV-16 E5 3’
GGCGGATCCGGTACCTATTTATGTAATTAAAAAGCGTGC
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The dominant negative ductin (Vma3p) construct was made in two stages. The 
first stage added the HA epitope tag and Pst 1 and Xho 1 restriction sites to allow 
directional cloning into pBluescript. The second stage mutated glutamate 137 to 
glycine, the final product being blunt-end ligated into pYPMA. The successive 
pairs of oligonucleotides are shown below, the mutated nucleotide being 
underlined and restriction sites in bold.
HA Vma3p 5’
GGGCTGCAGATGACTGAATTGTGTCCTGTC
HA Vma3p 3’
GGGCTCGAGTTAAGCGTAGTCTGGAACATCGTATGGGTAACAGACAACATCTTGAGTAGCC 
Vma3p E137G 5’
G ATTTT G ATTTT G ATTTT "f'G CT G G AGTTTT GGGTCTATACG GTTT
Vma3p E137G 3’
AAACCGTAT AGACCCAAAACTCCAGCAAAAAT CAAAATCAAAAT C
DNA templates for in vitro translation were synthesised by PCR, using 
oligonucleotides that included the T7 RNA polymerase promoter, to allow T7- 
mediated transcription, and a ‘Kozak’ sequence to ensure efficient (and 
consistent) translation of the RNA product. The T7 sites are underlined, and the 
Kozak sequences in bold. The HA T7 KOZAK oligonucleotide primed onto the 
HA-tag sequence so was also used for all of the E5 proteins except BPV-1 E5. All 
products were generated from pYPMA constructs so a universal 3’ 
oligonucleotide, PMArev was designed for simplicity. This oligonucleotide was 
also used for sequencing the constructs.
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Vma3p E137G T7 KOZAK 5’
AAAT AAT ACG ACT CACTAT AGGG AG AGCC ACCAT G ACT GAATT GT GTCCT GT C 
HA BPV-1 E5 T7 KOZAK 5’
AAAT AAT ACG ACT CACTATAG GG AG AGCC ACC AT G CC AAAT CTATACCCATACG
HA T7 KOZAK 5’
AAAT AATACG ACT CACTATAGGGAGAGCC ACCATGTACCCATACGAT GTT CCAG
PMArev 3’
GGGAAGTAAGAGTTGAAGCC
2.2.2 PCR
PCR amplification of the E5 protein ORFs was performed using PfuTurbo 
(Stratagene), a high-fidelity polymerase, to minimise the chances of introducing 
errors into the PCR products. 50ng of template and 12.5pmols of each 
oligonucleotide were used in each 50pJ reaction using the following cycles 
parameters.
Initial melt 94°Cx1min
Melt 94°C x 30sec
Anneal 55°C x 30sec 35 cycles
Extension 72°C x 1 min
Completion 72°C x 7min
The PCR products were electrophoresed alongside low mass markers (Life
Technologies) on a TAE (10mM Tris acetate pH8.0; 1mM EDTA) agarose gel at
100 volts for 30min. Bands corresponding to the correct product size were then
excised and their DNA extracted using the silica-gel based 'QIAquick' gel
90
extraction kit (Qiagen), according to the protocol, including addition of isopropanol 
to aid binding to the silica matrix. 80pJ of elution buffer was used in order to 
maximise the yield.
The ‘Quickchange’ kit (Stratagene) was used to generate the dominant negative 
form of Vma3p. A 50\i\ reaction was performed with 200ng of each 
oligonucleotide and 50ng of template using the following parameters.
Initial melt 94°Cx 1min
Melt 94°C x 30sec
Anneal 55°C x 1min 12 cycles
Extension 68°C x 18min
The ‘Quickchange’ PCR amplified the whole vector construct, so this was 
processed differently from the E5 ORF PCRs in that it was transformed directly 
into E. coli after removing the (unmutated) template by digestion with Dpn 1 
(Stratagene) for 1 hour at 37°C .
2.2.3 Restriction digestion and ligation
The purified products were digested with appropriate restriction enzymes at 37°C 
for 2 hours, the reactions being terminated by purification using a 'QIAquick' PCR- 
purification kit. Only 30pl of elution buffer was used to maximise concentration of 
the samples and aid ligation. Vectors were prepared by restriction digestion
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overnight, followed either by dephosphorylation with calf intestinal alkaline 
phosphatase (Life Technologies) for 30min at 37°C, or blunt end synthesis using 
polishing buffer and enzyme supplied with the pCRscript cloning kit (Stratagene). 
The PCR purification kit (Qiagen) was used to terminate the reactions and purify 
the DNA. The prepared PCR products were ligated to equimolar amounts of 
vector (as assayed by agarose gel electrophoresis), using a ‘Rapid Ligation’ kit 
(Roche).
2.2.4 E. coli transformation
DH5a competent cells (Life Technologies) were used for the majority of 
transformations. 1 pil of fresh ligation product or ‘Quickchange’ digest was mixed 
with 20pil of competent cells in a 1.5ml tube at 4°C. The cells were incubated at 
4°C for 30min then subjected to a 45 second heat shock at 42°C. The cells were 
incubated for 2min at 4°C and 100^1 SOC medium (Life Technologies) was added. 
The cells were then spread directly onto LB agar plates (containing 0.7%w/v bacto 
agar; 50|ig/ml ampicillin) and incubated overnight at 37°C. XL10-Gold 
ultracompetent cells (Stratagene) were used for transformation of constructs with 
low transformation efficiency, using the same protocol as above.
2.2.5 Plasmid DNA isolation and analysis
Plasmid DNA was extracted from 4ml cultures grown overnight in LB containing
200p,g/ml ampicillin using the 'Qiaprep' kit (Qiagen), according to the
manufacturer’s protocol. This uses the alkaline lysis method to extract the
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plasmid DNA, followed by purification on a silica matrix spin column. The purified 
DNA was digested and electrophoresed as for preparation of the PCR products. 
BamH 1 digestion detected the presence of inserts and Kpn 1 was used to 
determine their orientation with respect to the promoter (Kpn 1 sites being 200bp 
upstream of the cloning site, and at the 3’ end of the insert). Correctly assembled 
constructs were sequenced in both directions with external primers using the 
central automated sequencing facility.
2.2.6 Manipulation of Saccharomyces cerevisiae
2.2.6.1 Preparation of competent cells
200ml of cells were grown in complete glucose medium overnight at 30°C to an 
optical density of 0.6 at 600nm and harvested at 2000xg for 5min at room 
temperature. Cells were washed in 50ml sterile water, then in 40ml filter-sterilised 
SORB (1M Sorbitol; 100mM Lithium acetate; 10mM Tris-acetate pH8; 1mM 
EDTA.). The supernatant was removed completely, the cells resuspended in 
1.5ml SORB, and 200pl carrier DNA added. (10mg/ml salmon sperm DNA, boiled 
for 1min, sonicated at 10pm for 1min.) The cells were stored in 20pl aliquots at - 
70°C.
2.2.6.2 Yeast transformation
100ng plasmid DNA was incubated with 20pl competent cells and 120pl filter- 
sterilised PEG (40%w/v polyethylene glycol 3350; 100mM lithium acetate; 10mM
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Tris-acetate pH8; 1mM EDTA) for 30min at room temp, then 15 i^l DMSO was 
added and the cells placed at 42°C for 15min. The cells were harvested at 
15,000xg for 1min, resuspended in 100^1 minimal medium and spread onto 
minimal medium plates containing 2%w/v bacto agar.
2.2.6.3 Yeast DNA purification
The 'QIAprep' protocol was modified to allow yeast lysis by the buffers supplied in 
the kit. 15ml of yeast were grown to logarithmic phase in minimal medium, 
harvested at 3,000xg for 5min at room temperature then resuspended in 3ml 
digest buffer (1M sorbitol; 50mM Na2HP04/NaH2P04  pH7.5; 2%w/v glucose; 
0.4%v/v |3-nnercaptoethanol; 0.5mg/ml yeast lytic enzyme). This was incubated for 
30min before harvesting the spheroplasts at 2,000xg for 5min at room 
temperature. The plasmid DNA was isolated using the ‘Qiaprep’ kit as for 
bacterial cells, using only 30|il elution buffer to take into account the low yield 
obtained from yeast.
2.2.6.4 Vacuole isolation
This was performed using the method of (Uchida et al., 1985). 200ml yeast 
cultures were grown in minimal medium overnight at 30°C to an optical density of 
between 0.5 and 1 at 600nm. Sugar (glucose or galactose/raffinose, see section 
1.3.6.5) was added to restore the concentration to 2%(w/v) 2 hours before the 
cells were harvested at 5,000xg for 5min at room temperature. The cells were 
then washed in 20ml phosphate buffer (50mM Na2HP0 4/NaH2P04 pH7.5), using
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50ml tubes to minimise loss of material during subsequent liquid transfers. 
Spheroplasts were prepared by resuspending in 20ml of digest buffer (1M sorbitol; 
50mM Na2HP04 /NaH2P0 4 pH 7.5; 2%w/v sugar source; 0.4%v/v p-
mercaptoethanol; 0.5mg/ml yeast lytic enzyme) and incubating at room 
temperature for 1 hour. The spheroplasts were harvested at 2,000xg for 5min at 
room temperature and placed on ice, with all subsequent steps being carried out 
at 4°C. Of note is the presence of sugar for 3 hours before harvesting, which is 
necessary to prevent starvation-induced inactivation of the V-ATPase (Kane,
1995), section 1.3.6.5.
The spheroplasts were resuspended by vortex mixing in 6ml of floatation buffer 
(8%w/v Ficoll 400; 10mM MES-Tris pH6.9; 0.5mM MgCI2; 0.1 mM 4-(2-
Aminoethyl)-benzenesulphonylfluoride, AEBSF; 1 mM Benzamidine), then lysed by 
four strokes in a loose-fitting homogeniser. The suspension was poured into a 
Beckman SW40 thin-walled polyallomer tube, overlaid with floatation buffer and 
centrifuged at 51,900xg for 30min. The layer of vacuoles was harvested from the 
top of the tube with a spatula and resuspended in 1.5ml buffer C (10mM MES-Tris 
pH6.9; 5mM MgCI2; 25mM KCI; 0.1 mM AEBSF; 1mM benzamidine). The 
vacuoles were harvested by centrifugation at 20,000xg for 5min, resuspended to 
approximately 2mg/ml in buffer C and either used immediately or stored at -70°C 
in buffer C containing 10% glycerol (w/v)
Because of the slow growth in minimal medium, larger preparations were grown 
using complete medium. The 2p,-based plasmids are stable under non-selective 
conditions (Ludwig and Bruschi, 1991) and no effects of plasmid loss were seen 
(Figure 4.13).
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2.2.7 Analysis of the vacuolar proton-translocating ATPase (V-ATPase)
2.2.7.1 Purification of the V-ATPase
This was performed using the method of (Uchida etal., 1985), with adaptations for 
use on a benchtop ultracentrifuge. 1 mg aliquots of vesicles were washed twice in 
TE (10mM Tris-CI pH7.5; 1mM EDTA), harvesting by centrifugation at 400,000xg 
for 10min at 4°C. The final pellet was resuspended in the residual buffer, to which 
was added 50pJ of 10%(w/v) N-dodecyl maltoside solution and 5pil yeast protease 
inhibitor cocktail (Sigma). The solution was mixed by slow pipetting, and then 
incubated at 4°C for 15min to solubilise the membrane proteins. Insoluble 
material was removed by centrifugation at 400,000xg for 10 min at 4°C and the 
supernatant carefully loaded onto 2ml of a 10 step density gradient (20%-50%w/v 
glycerol; 10mM Na-HEPES pH7.5; 50mM NaCI; 0.01 %v/v yeast protease 
inhibitor cocktail.) Centrifugation was carried out in a TLS-55 swing-out rotor at 
200,000xg for 5 hours at 4°C using the minimum acceleration and deceleration. 
200pJ fractions were collected into a 96-well plate by upward displacement using 
fluorinert (3M).
2.2.7.2 Protein estimation
This was performed using the bicinchoninic acid (BCA) method. BCA reagent 
(Sigma) was prepared fresh, by addition of 0.02 volumes of 5%(w/v) 
copper(ll)sulphate to BCA solution. To this, an equal volume of 0.1%w/v SDS 
was added, and the mixture dispensed in 1ml aliquots. Approximately 5p,g of
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protein was added and the reaction mixed and incubated at 65°C for 30min. 
Absorbance at 562nm was measured and the protein concentration deduced from 
a standard curve of bovine serum albumin.
2.2.7.3 Measurement of V-ATPase activity
The rate of ATP hydrolysis was determined by measuring the amount of 
phosphate released in saturating concentrations of ATP. Specific activity was 
determined from the activity inhibited by N’N-dicyclohexylcarbodiimide (DCCD) in 
the presence of sodium azide (see section 4.3).
Duplicate reactions were set up, containing 200^1 buffer C containing 0.02% w/v 
sodium azide and 5pil («10[xg protein) of vacuoles. 5pJ ethanol, with or without 
5mg/ml DCCD was added to the respective sets of reactions which were briefly 
vortex mixed and then incubated at room temperature for 5 min. 30\i\ ATP (50mM 
in buffer C) was added to all reactions, which were then vortex mixed and 
incubated at 30°C for 30 min. The reaction was terminated, and the phosphate 
release determined by using a modification of the ammonium molybdate-based 
technique (Piper and Lovell, 1981). 750fxl phosphate detection reagent (2%v/v 
sulphuric acid; 1%w/vSDS; 0.5%w/v ammonium molybdate; 0.1 %w/v ascorbic 
acid.) was added to the reaction and the absorbance at 830nm measured after 
10min. Phosphate concentrations were determine from a standard curve of 
Sodium phosphate.
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For microplate assay of the purified V-ATPase, 50pJ buffer C containing 5mM ATP 
and 0.02%w/v sodium azide was added to 5-30^1 aliquots from the gradient 
fractions. The reactions were mixed, incubated at 30°C for 30min, developed 
using 100|il double-concentrate phosphate detection reagent, and the absorbance 
measured at 630nm against a standard curve of sodium phosphate. Kinetic 
analysis was performed in the same way, using 1-2pg vacuoles per well. For N- 
ethyl maleimide (NEM) sensitive ATPase activity determination, NEM was added 
to lOO^M for 5min before addition of ATP.
2.2.8 In vitro binding assays 
2.2.8.1 Capped RNA synthesis
The 'T7 mMessage mMachine' kit (Ambion) was used according to the 
manufacturer’s protocol, doubling the reaction size to increase yield. The RNA 
was precipitated using the lithium chloride method, concentration estimated by 
agarose gel electrophoresis, and adjusted to 0.5mg/ml. For shorter transcripts (all
i
of the E5 protein constructs) the T7 ‘MEGAshortscript’ kit (Ambion) was used 
instead, following the manufacturer’s protocol but including the cap analogue, 
(m7G(5’)ppp(5’)G) (Ambion) and modifying the size of the reaction as above.
2.2.8.2 In-vitro translation
Rabbit reticulocyte lysate (Promega) was used to synthesise proteins in the 
presence of canine pancreatic microsomes (Promega), to allow signal-mediated
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translation of the proteins (Dunlop et al., 1995) and allow their primary purification 
by centrifugation. 35S-Cysteine and 35S-methionine (Amersham) were included to 
allow radiological detection. The reactions were carried out according to the 
manufacturer’s protocol, using a total of 1 \ig RNA per reaction. Microsomes were 
collected by centrifugation at 400,000xg for 10min and resuspended in 400pJ 
radoimmuniprecipitation (RIPA) buffer (20mM Na-MOPS pH7.5; 150mM NaCI; 
10mM EDTA; 5mg/ml Triton X-100; 5mg/ml sodium deoxycholate; 1 mg/ml SDS).
2.2.8.3 Immunoprecipitation
Five microlitres of anti-HA1 (E5 proteins) and anti-AU1 (ductin) antibodies were 
added to respective 200ptl aliquots of the solubilised microsomes, to which a 
further 200pJ radioimmunoprecipitation assay (RIPA) buffer was added. The 
mixture was then placed on a rotary mixer overnight at 4°C. 10pil protein D- 
sepharose was added and mixing continued for 1 hour at room temperature 
before harvesting the sepharose by centrifugation at 20,000xg for 5min. The 
samples were washed three times in 500pil RIPA, the final wash including 
incubation on a rotary mixer for 15min. The final pellet was resuspended in 10 i^l 
2xSDS loading buffer (100mM Tris-CI pH6.8; 10%w/v glycerol; 5%w/v SDS; 
0.2%w/v bromophenol blue), which was electrophoresed on a 15% Tris-tricine 
polyacrylamide gel to optimise the resolution of the small proteins. The gel was 
fixed in 50%v/v methanol, 10%v/v acetic acid for 1 hour, dried onto Whatman 
paper and used to expose film (Fuji super RX) for approximately one week.
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2.2.9 Protein analysis
2.2.9.1 Protein precipitation
Acetone:ethanol was chosen because it delipidated the sample and so improved 
the migration properties on SDS-PAGE. Four volumes of acetone:ethanol (1:1) 
were added to the protein sample, which was vortex-mixed and incubated at - 
20°C for 30min. The protein was collected by centrifugation at 20,000xg for 
30min, and the supernatent removed completely. The sample was resuspended 
at 37°C in SDS loading buffer (50mM Tris-CI pH 6.8; 5%w/v glycerol; 2.5%w/v 
SDS; 0.1%w/v bromophenol blue).
2.2.9.2 Tris-glycine SDS-PAGE
The larger V-ATPase subunits, Vmalp and Vphlp were separated using 10% Tris 
glycine polyacrylamide gels, prepared according to the method of (Laemmli, 
1970). All protein electrophoresis was carried out using the NOVEX mini-gel 
system (Invitrogen), which allowed rapid processing without loss of resolution. 
Pre-stained markers (Amersham) were used to estimate the mass of the proteins 
in the gel.
2.2.9.3 Tris-tricine SDS-PAGE
All other protein separations by SDS-PAGE were carried out according to the 
method of (Schagger and von Jagow, 1987). Substituting glycine with tricine
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improved the separation of smaller proteins from the SDS in the loading buffer, 
increasing their resolution during electrophoresis. 15% gels were prepared 
according to the protocol, including 10%(w/v) glycerol in the separating gel to allow 
direct overlaying of the 4% stacking gel. The gel contained high concentrations of 
Tris, which diffused into the wells and prevented samples from sinking completely, 
so the sample wells were thoroughly rinsed with cathode buffer (0.1 M Tris; 0.1 M 
tricine; 0.1%w/v SDS) before sample application.
2.2.9.4 Western blotting
Proteins separated by SDS-PAGE were transferred onto Hybond nitrocellulose 
membrane (Amersham) using a semi-dry blotting apparatus. The apparatus was 
assembled with the gel placed against the nitrocellulose membrane and 
sandwiched between stacks of six sheets of Whatman paper soaked in transfer 
buffer (100mM Tris; 100mM glycine; 0.1%w/v SDS), with 20%(v/v) methanol being 
included for Vmalp and Vphlp. A glass pipette was rolled over the surface to 
remove any air bubbles, and a current of 1mA/cm2 was applied for 1 hour (2 hours 
for Vphlp). The efficacy of protein transfer was verified by staining in Ponceau S 
(Sigma) for 10min followed by 4x1 min rinses in water.
The membrane was transferred to block solution (10mM Tris-CI pH 7.5; 50mM
NaCI; 0.01 %w/v TWEEN; 10%w/v skimmed milk powder, Marvel) for 30min
before rinsing in TBST (10mM Tris-CI pH 7.5; 50mM NaCI; 0.01 %w/v TWEEN)
and incubating overnight at 4°C in primary antibody diluted 1000-fold in TBST
containing 0.1% (w/v) Marvel. The membrane was rinsed four times in TBST and
incubated for 1 hour in horseradish peroxidase-linked secondary antibody
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(Amersham), diluted 5000-fold in TBST containing 0.1% (w/v) Marvel. To remove 
non-specifically bound antibody the membrane was rinsed twice in TBST, then 
four times for 10min. The membrane was then incubated in chemiluminescent 
detection solution (Amersham) for 1min, drained, and exposed to film (Kodak 
super RX) for 5 seconds to 1 hour, depending upon the intensity of the signal.
2.2.9.5 Dot blotting
To aid binding to the membrane, 10pig aliquots of vacuolar protein samples were 
precipitated in acetone:ethanol as described previously, then taken up in SDS 
loading buffer and spotted directly onto nitrocellulose membrane. The samples 
were allowed to dry completely before blocking and processing as for Western 
blots.
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3. Results. Generation of epitope-tagged E5 protein 
pYPMA constructs: binding to yeast ductin and correct 
expression in S. cerevisiae
3.1 Introduction
As explained in chapter 1, Saccharomyces cerevisiae is a convenient model 
organism to use for studying the effects of the E5 proteins. The homology 
between S. cerevisiae and mammalian forms of ductin, and the demonstration of 
BPV-1 E5 binding to the S. pombe form (Goldstein et al., 1992c) suggest that the 
E5 proteins will bind to the S. cerevisiae form. The similarities between 
mammalian and yeast protein expression and targeting mechanisms would also 
suggest the correct expression of the E5 proteins in transformed yeast strains.
To confirm these assumptions, HA-tagged E5 constructs were generated by PCR 
and cloned into the yeast expression vector, pYPMA. The binding of the products 
from these constructs to S. cerevisiae ductin was verified by co-translation on 
microsomes in vitro, followed by immunoprecipitation. The stability and integrity of 
the constructs in vivo was confirmed by PCR, and correct protein expression by 
western blotting and dot blotting.
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3.2 PCR generation of epitope-tagged E5 protein constructs and 
demonstration of binding to Saccharomyces cerevisiae ductin in vitro
The expression vector for the E5 proteins was pYPMA (Figure 3.1 A); a derivative 
of the pYES2 vector (Invitrogen), which was constructed by replacing the GAL1 
promoter construct of pYES2 with that of the yeast plasma membrane ATPase; 
PMA1 (Villalba et al., 1992). Other features of the vector are a URA3 gene, which 
allows for transformant selection by uracil omission from minimal medium, and a 
2\x replication origin to maintain the plasmid at a high copy number and maximise 
expression levels. A pMB1 replication origin and a p-lactamase ampicillin 
resistance gene are present to allow propagation in E. coli. This vector was 
chosen because it had previously been shown to drive particularly high levels of 
integral membrane proteins in yeast (Jones et a!., 1995), and so would maximise 
any effects of the E5 proteins.
In addition to investigating the wild type E5 proteins, three mutant forms of BPV-4 
E8 were included, which all bind to ductin but differ in their transforming capacities 
and their ability to disrupt one activity associated with ductin: gap junctional 
intercellular communication (GJIC) (Ashrafi et al., 2000; O'Brien et al., 1999). 
Wild type BPV-4 E8 induces anchorage-independent growth and reduces contact 
inhibition and GJIC in primary bovine fibroblasts. The N17S mutant confers 
anchorage independent growth, as seen for wild type E8, but does not inhibit 
communication or cause cells to overcome contact inhibition. The N17A mutant 
is a hypertransforming form that has all the properties of wild type E8, but induces 
higher levels of anchorage independent growth. The truncated E8 mutant (BPV-4
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E8T) lacks the hydrophilic carboxy terminus of the protein and does not cause 
transformation or inhibit communication.
A positive control for V-ATPase inhibition was also included, a dominant negative 
form of ductin with the active glutamic acid mutated to glycine. Expression of this 
type of mutant has been shown to disrupt the V-ATPase in yeast, (Hughes et al.,
1996) and also to cause cell transformation (Andresson eta!., 1995).
The ORFs for the E5 proteins were available in mammalian expression vectors, 
and the HA-tagged BPV-4 E8 constructs were cloned from laboratory stocks into 
pYPMA by Joan Grindlay (Beatson Institute for Cancer research, Glasgow, UK). 
In order to add the HA epitope tag, and the BamH 1 and Kpn 1 restriction sites for 
cloning and analysis, PCR was performed upon the ORFs using oligonucleotides 
containing these motifs. A high fidelity DNA polymerase (Pfu, Stratagene) was 
used to minimise the introduction of errors during synthesis. The BamH 1 sites 
allowed direct ligation into pYPMA, and the Kpn 1 site made it possible to exploit 
the upstream Kpn 1 site in the vector and screen for correct orientation by 
restriction digestion; the site being placed at the 3’ oligonucleotide, so digests 
yielding excised fragments of higher mass indicating the correct orientation. This 
screen was also useful for detecting insertion of concatamers which gave more 
than one species of excised DNA. Oligonucleotides specific for pYPMA, directed 
against sequences adjacent to the cloning site were used to sequence the 
constructs, the results being shown in Figure 3.1 B.
The sequencing data confirm the sequence integrity of the ORF PCR products, 
and their correct ligation into pYPMA. Despite use of a high fidelity polymerase,
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errors did occur in HTLV-1 p121 and in BPV-4 E8 N17A. However, the p121 protein 
sequence was unaffected, and the difference caused by mutation of a leucine to a 
valine in the E8 construct was decided to be too small to be of any consequence; 
both residues have very similar size, shape and hydrophobicity, differing only by 
one methyl group.
The dominant negative ductin construct (Vma3p E137G) was constructed such 
that it and the unmutated form could also be ligated into other yeast expression 
vectors based on pBLUEscript (Stratagene). To this end, the HA tag, and Pst 1 
and Xho 1 restriction sites were added to S. cerevisiae ductin (VMA3) by PCR, 
with the product being cloned into pYPMA by blunt end ligation and sequenced as 
before. The correctly oriented construct was then used as a template for site 
directed mutagenesis by PCR, using the Quickchange kit (Stratagene). A final 
round of sequencing was performed to confirm the mutation and check sequence 
integrity, shown in Figure 3.1.
To verify binding between the E5 proteins and S. cerevisiae ductin, both were 
translated in the presence of microsomes in vitro and analysed by 
radioimmunoprecipitation. DNA templates were generated by PCR using 
oligonucleotides containing identical T7 bacteriophage RNA polymerase 
recognition sites, and ‘Kozak’ mammalian ribosome docking sequences to 
encourage similar levels of transcription and translation. RNA transcripts were 
generated by the T7 mMessage mMachine kit (Ambion) and translated in the 
presence of microsomes. These endoplasmic reticulum (ER) derived vesicles are 
required for signal-recognition particle (SRP) dependent translation of ductin and 
the E5 proteins (Dunlop et ai., 1995; Faccini et al., 1996). They also permit
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interactions to occur in a membranous environment, and allow primary purification 
of membrane proteins from the reaction by centrifugation. 35S-labelled methionine 
and cysteine were included to allow the translation products to be tracked by 
autoradiography. The proteins contained different proportions of sulphydryl 
residues so the RNA levels were adjusted to minimise the differences in the 
amount of labelling and so aid visual analysis of autoradiographs.
Before testing the binding capacities of the proteins, it was necessary to check the 
ability of the system to correctly translate and detect them. To this end, single 
translations were carried out and the proteins precipitated with both types of 
antibodies. The results of SDS-PAGE and autoradiography of the samples are 
shown in Figure 3.2 A. The precipitation of the proteins by antibodies to their 
epitope tags confirms the specificity of the antibodies and also confirms the 
correct translation of the epitope tags on the proteins. The correct size of the 
proteins and their presence in the microsomal membranes suggests that all of the 
proteins were correctly translated in vitro. HTLV-1 p121 seems to have been 
affected by a gel artefact, but this is resolved in subsequent experiments (Figure
3.2 B).
Co-translations were carried out to test for interactions between the E5 proteins 
and Vma3p, with RNA levels adjusted to give similar levels of 35S incorporation for 
the different proteins. Translation of the E5 proteins in the presence of Vma3p 
followed by immunoprecipitation and SDS-PAGE (Figure 3.2 B) demonstrates 
interaction between the two proteins. A control was attempted, using PPA1 which 
has previously been shown not to bind to the E5 proteins (Faccini et ai., 1996) but 
correct translation could not be achieved so the validity of the results was inferred
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from the fact that the experimental conditions were identical to those previously 
used to show specific interactions between Nephrops ductin and E5 proteins 
(Faccini etal., 1996), (I. Rodriguez, manuscript in preparation).
The E5 proteins of BPV-1 and HPV-16 co-precipitate with Vma3p irrespective of 
which protein the antibody is directed against. The same also occurs for HTLV-1 
p121, suggesting that these three proteins bind to S. cerevisiae ductin. BPV-4 E8 
is only detected when precipitated via anti-AU1 in co-translations, consistent with 
published results (Faccini et al., 1996). This could represent a weaker 
association, or could be due to poor translation when having to compete with the 
Vma3p template in the co-translation reaction. However, the mutant forms of 
BPV-4 E8 all bind to S. cerevisiae ductin to a similar level. They have also been 
shown to bind to Nephrops ductin in a similar manner (Ashrafi et al., 2000). 
Because the truncated mutant has almost no hydrophilic domains, it demonstrates 
its interaction with ductin is most likely mediated by its transmembrane domain, 
consistent with results published for BPV-4 E8 and BPV-1 E5 (sections 1.1.5.1 
and 1.1.5.3) as well as unpublished data on HPV-16 E5 (I. Rodriguez, manuscript 
in preparation).
The significance of the varied intensities of the proteins is not known. It may be 
due to differences in the levels of translation, possibly as a result of competition 
from the Vma3p template. However it is unlikely to explain the differences 
between the E8 constructs, which are almost identical in sequence so their varied 
intensities may represent differences in binding affinity to ductin.
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In summary, all of the E5 proteins co-immunoprecipitated with Vma3p, showing for 
the first time that they are capable of binding to S. cerevisiae ductin and verifying 
its use as a model to study the effects of these proteins on the V-ATPase.
3.3 Viral E5 proteins bearing amino terminal epitope tags are expressed in 
S. cerevisiae and are found in the vacuolar membrane
The E5 proteins have been shown to bind to S. cerevisiae ductin, so the effects of 
their expression in vivo can now be examined in the light of early indications of V- 
ATPase inhibition, found by Meagher and Finbow (Figure 6.2). To this end, the 
YPH 500 strain was used since it has been used in other studies on the V-ATPase 
(Umemoto et al., 1991) and it is auxotrophic for uracil, allowing pYPMA 
maintenance by nutrient selection. The ade2 genotype also causes accumulation 
of a red pigment in the vacuole (Ugolini and Bruschi, 1996) which is dependent 
upon V-ATPase activity (Figure 4.3), providing another method of screening for 
disruption of the enzyme. The haploid strain was transformed with pYPMA 
constructs containing the HA-tagged E5 protein ORFs, the HA-tagged dominant 
negative ductin construct, as a positive control, and the empty pYPMA vector as a 
negative control. Transformants were selected by growth on medium lacking 
uracil, then tested for their ability to maintain the pYPMA constructs, and correctly 
express and target the proteins.
To check the integrity of the ORFs in pYPMA, PCR analysis was used to
determine if the plasmids were maintained in the transformants. Plasmid DNA
was isolated from equal amounts of yeast grown in minimal medium, and PCR
performed using oligonucleotides specific for the insert and the vector; the 5’
109
oligonucleotides being directed against the PMA1 promoter sequence, and the 3’ 
oligonucleotide against the 3’ end of each of the inserts. The ‘no template’ control 
reaction contained all of the oligonucleotides to check for contamination.
Figure 3.3 shows the result of agarose gel electrophoresis of the products from 
the reactions. The products were of the expected size, confirming the presence of 
correctly oriented E5 protein ORFs in pYPMA in the transformed yeast strains. 
The BPV-4 E8 constructs should have migrated to the same position as BPV-1 
E5, but because they were ligated into pYPMA as fragments excised from another 
vector it is possible that upstream sequence from their original vector was 
incorporated, increasing their apparent size. The small product seen in the empty 
vector lane was expected since the oligonucleotides in this reaction were 20 
nucleotides in length and directed against sequences 40bp apart.
Because codon preferences vary between different organisms, this may effect the 
translation of the E5 proteins oustide their natural hosts. None of the E5 proteins 
are naturally expressed in yeast and although the presence of the desired plasmid 
constructs suggests expression of the protein, the only way to be certain is to 
detect the proteins directly. BPV-1 E5 and HPV-16 E5 have been detected 
previously by western blotting (Burkhardt et al., 1989; Hwang et al., 1995), but 
p12* and E8 have not.
Because the V-ATPase is predominantly found in the yeast vacuole, 
immunoblotting was carried out on purified vacuolar membranes, the results being 
shown in Figure 3.4 A. The dominant negative form of ductin and HPV-16 E5 
were detected by western blotting, their molecular masses corresponding with
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those expected, and those seen in in vitro translation. This evidence for correct 
expression and vacuolar targeting of the proteins in vivo is reinforced by the 
observation of higher order species, which have been seen in other preparations 
of these proteins (Burkhardt etal., 1989; Hwang etal., 1995).
The reasons why the other E5 proteins were not detected are not known. It may 
be that their small size may have caused them to pass through nitrocellulose 
during electroblotting, but molecular markers were visible at the expected size 
interval, and reducing the membrane pore size and the transfer voltage made no 
difference, as did increasing the methanol concentrations. Using different buffer 
systems at all stages of the protocol also had no effect (positive or negative) so 
the problems could be pleiotropic, perhaps due to the combination of small size 
and high hydrophobicity. It could also be due to inaccessibility of the epitope tag. 
The N-termini of the proteins only remain hydrophilic for a few residues, and the 
hydrophobic region may repel antibody molecules. Possible solutions might be to 
attach multiple tags or to use a larger tag, or a hydrophilic ‘linker’ peptide to 
distance the epitope from the protein. Detection of BPV-4 E8 by western blotting 
and immunofluorescence has been performed using Green Fluorescent Protein 
(GFP) as an epitope tag (M. Zago, personal communication), but it is not known 
whether this affects the transforming potential of the protein.
An alternative strategy was tried to circumvent this problem. 10pg aliquots of 
vacuolar protein were precipitated in acetone:ethanol, solubilised in SDS loading 
buffer and spotted directly onto the nitrocellulose membrane, the results of 
immunodetection being shown in Figure 3.4 B. With this approach, the dominant 
negative ductin and HPV-16 E5 gave the strongest signal, corresponding to their
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being detectable by western blotting, however, the relative intensities were not the 
same as those seen in western blotting, so it seems that either electrophoresis 
and blotting changes the affinity of the proteins for the antibody (possibly by 
altering the accessibility of the epitope tags), or that some of the protein is lost 
during concentration. The latter possibility is supported by the variations in 
reactivity seen for the E8 proteins, which would have been expected to react 
equally given their sequence similarity.
The in vitro translation experiments have shown that the E5 proteins bind to the 
S. cerevisiae form of ductin, and western blotting confirmed the correct expression 
of the dominant negative form of ductin and HPV-16 E5 in vivo. Although that of 
the other E5 proteins could not be verified directly, their correct expression was 
inferred from sequencing data and PCR analysis showing the integrity of the 
sequences and plasmid maintenance in vivo, and dot blot analysis of vacuolar 
protein showing expression of HA-tagged proteins in the vacuole.
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Figure 3.1 pYPMA vector map and sequences of the E5 protein constructs
A: pYPMA contains a pMB1 replication origin and ampicillin resistance gene to allow propagation in 
bacteria, the 2\i origin and URA3 gene to allow maintenance of high copy number in yeast using 
uracil deficient medium, a PMA1 promoter to drive high levels of transcription, a BamH 1 cloning 
site and a Kpn 1 site to enable directional analysis by restriction digestion.
B: The E5 protein and dominant negative ductin constructs were sequenced in both directions to 
verify their integrity and orientation. Vector sequences are underlined, mutations and the 
haemagglutinin epitope tag being shown in red. HTLV-1 p12! contained a point mutation which did 
not affect the protein sequence. The BPV-4 E8 N17A mutant contained a point mutation which 
converted a leucine to a valine.
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Figure 3.2 In vitro E5 protein binding assays
To assess if the E5 proteins bound to the S. cerevisiae form of ductin (Vma3p), the proteins were 
translated in vitro in the presence of microsomes and 35S-labelled methionine and cysteine. The 
microsomes were collected by centrifugation, solubilised in RiPA buffer, split into two equal volumes 
and incubated overnight at 4°C with antibodies to the AU1 and HA1 epitopes, which bind to the 
epitope-tagged Vma3p and E5 proteins respectively. The bound proteins were precipitated by 
incubation with sepharose-linked protein G for one hour, washed three times in RIPA buffer, taken 
up in sample loading buffer and run on 15% Tris-tricine gels. These were fixed in 50% methanol 
10% acetic acid for one hour, vacuum dried onto Whatman paper and exposed to autoradiographic 
film for 2-20 days. The single translation gels (A) verify the correct translation of the proteins and 
specificity of the antibodies to their respective epitopes. In co-translations (B), BPV-4 E8 and its 
truncated mutant are harder to detect by HA 1 precipitation than in single translations, which may be 
due to competition by the Vma3p template. All of the E5 proteins co-immunoprecipitated with 
Vma3p, demonstrating binding in vitro.
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Figure 3.3 PCR analysis of plasmid DNA isolated from transformants
To confirm the presence and integrity of the pYPMA constructs in the yeast transformants, PCR 
was performed using one oligonucleotide directed against the PMA1 promoter and one against the 
3’ terminus of the constructs, (or a site upstream of the cloning site in the case of the empty vector 
control). The ‘no template’ control contained a mixture of all of the oligonucleotides. The products 
were run on a 2% TBE agarose gel stained with ethidium bromide and visualised under ultra-violet 
light. The presence of bands at the expected size intervals confirmed that the plasmids were 
correctly maintained in vivo.
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Figure 3.4 Immunodetection of tagged proteins in yeast vacuoles
Aliquots of vacuoles containing 10\ig of protein were either run on a 15% Tris-glycine 
polyacrylamide gel and electroblotted onto nitrocellulose membrane (A), or precipitated in 
acetone:ethanol, solubilised in SDS loading buffer and spotted directly onto the membrane (B). 
Chemiluminescent immunodetection was performed using 5\ig/ml of 12CA5 monoclonal anti-HA 
antibody (Roche) in TBST. The dominant negative ductin mutant and the HPV-16 E5 proteins were 
detected at the correct size intervals on the western blot (A), confirming correct translation and 
vacuolar targeting in vivo. Dot blotting detected the other E5 proteins, with variations in their levels 
of detection.
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4. Results: Analysis of the E5 proteins using S.
cerevisiae supported on glucose
4.1 Introduction
The binding of BPV-1 E5 to ductin involves the glutamic acid at the active site of 
ductin (Andresson et al., 1995), which has also been shown to lie on the outside 
face of the Vo complex with partial exposure to lipid (Harrison et al., 1999). If the 
mechanism of rotational catalysis is the same as that of F-ATPase (Stock et al., 
1999), this binding would cause steric hindrance, and may inhibit the rate of 
catalysis, consistent with observations by Finbow and Meagher (Figure 6.2). Both 
the BPV-4 and HPV-16 proteins have been shown to disrupt another activity 
associated with ductin, gap junctional intercellular communication (Faccini et al., 
1996; Oelze et al., 1995). Again, in this form of ductin complex, the critical 
glutamic acid is exposed to lipid (Finbow et al., 1992), however, inhibition of GJIC 
does not fully correlate with the transforming ability of E8 (Ashrafi et al., 2000), so 
if ductin-binding does account for a conserved mode of transformation it is likely to 
be via effects on the V-ATPase.
Efficient translation and ductin-binding has been demonstrated for all of the 
proteins in the previous chapter, so the first step towards investigating their effects 
upon the V-ATPase is to express them in yeast grown in optimal conditions, 
thereby maintaining the V-ATPase in its fully assembled state.
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The effects of the E5 proteins on the ATP hydrolysis and proton translocation by 
the V-ATPase were probed by a number of means; the amenability of yeast 
towards vacuole isolation making it possible to study the enzyme in more detail, 
both in terms of kinetics and of assembly of the enzyme. To maintain optimal 
glucose levels, and prevent starvation-induced enzyme inactivation, (Parra and 
Kane, 1998), glucose concentrations were restored two hours before harvesting, 
and maintained at all stages prior to cell lysis.
4.2 Overexpression of ductin-binding E5 proteins does not affect cell 
viability
One of the difficulties of expressing foreign proteins at high levels is that they may 
exert toxic effects not seen when expressed at their normal levels in their usual 
host cell. A well characterised instance of this is in bacterial overexpression 
systems, where cell death is a major obstacle (Studier et al., 1990). BPV-4 E8 
overexpression with ras is lethal in primary bovine fibroblasts (Pennie etal., 1993), 
so to rule out any similar effects in yeast, growth rates were determined for the 
yeast transformants, using minimal medium buffered to pH5.5 to preserve the 
plasmid levels whilst removing the direct influence of the V-ATPase on cell 
viability. The optical densities of exponential phase cultures were monitored over 
eight hours and plotted on a logarithmic scale graph, shown in Figure 4.1. The 
average growth rates were calculated from the gradients of the curves, and 
converted into doubling times (Figure 4.2).
YPH 500 cells containing the empty vector had a doubling time of approximately
three hours. Cells expressing any of the E5 proteins had similar doubling times
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confirming that overexpression of these proteins is not deleterious to growth. 
However, both the ductin knockout (W303-1B Vatc) and dominant negative ductin 
strains grew at around half the rate of that of cells bearing the empty vector, 
suggesting that V-ATPase disruption even affects growth at low pH. This is 
probably due to mitochondrial dysfunction as a side-effect of V-ATPase inhibition 
(Eide et al., 1993). A consequence of mitochondrial dysfunction is the ‘pet’ 
phenotype; an abbreviation for ‘petite’, describing the small colonies seen when 
grown in medium where the principal carbon source is non-fermentable 
(Whittaker, 1979). Because strains expressing the E5 proteins grew at a different 
rate to the strain expressing the dominant negative form of ductin, it suggests that 
they may have different effects upon the V-ATPase.
4.3 The E5 proteins do not affect vacuolar acidification or the rate of ATP 
hydrolysis by the V-ATPase
To test for vacuolar disruption by the E5 proteins, the transformed yeast strains 
were inoculated onto solid medium containing either 100mM calcium chloride, or 
buffered to pH 7.5, which select for V-ATPase function in yeast. Non-selective 
plates, buffered to pH 5.5 were included as controls, with representative results 
from experiments repeated at least three times being shown in Figure 4.3. Both 
the ductin knockout and the dominant negative transformant, Vma3p E137G, 
failed to grow at pH 7.5 but the dominant negative form grew slowly in complete 
medium containing calcium, suggesting that the stringency varies with the type of 
screening and the nutrient composition of the medium. The loss of red colouration 
of the V-ATPase-defective strains when grown on complete glucose medium at 
pH 5.5 confirms the use of this visual test to detect inhibition of the V-ATPase.
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However all of the strains expressing the E5 proteins grew to the same extent as 
the wild type, with growth on minimal medium confirming that this was not due to 
plasmid loss. Taken together, these data suggest that the E5 proteins do not 
inhibit the V-ATPase to the same extent as that seen by expression of the 
dominant negative form of ductin. However, published data show that only a low 
level of V-ATPase activity is required to permit growth at high pH (Finbow et al., 
1994) consistent with results presented in chapter 5 showing that growth at high 
pH (Figure 5.4) still occurs despite a 65% loss of V-ATPase activity due to 
substitution of glucose for galactose/raffinose (Figure 5.1). So it is possible that 
the E5 proteins cause only partial inhibition, which is not detected by this assay. 
To address this possibility, the V-ATPase activity of the transformed strains was 
quantified. Proton pumping is tightly coupled to Magnesium ATP hydrolysis in the 
V-ATPase (Puopolo et al., 1992b; Zhang et al., 1992), so the effects of the E5 
proteins on the enzyme could be determined by measuring the rates of ATP 
hydrolysis of the purified V-ATPase.
Standard isolation procedures are available to isolate milligram quantities of 
vacuoles and a number of V-ATPase inhibitors are available for determination of 
enzyme activity; bafilomycin Ai, concanamycin A, dicyclohexylcarbodiimide 
(DCCD) and N-ethylmaleimide (NEM) (Arai et al., 1987a; Drose and Altendorf, 
1997; Flatmark et al., 1982). Concanamycin A and bafilomycin Ai are the most 
specific in activity (Drose and Altendorf, 1997) but are expensive and difficult to 
store. NEM has none of these drawbacks, but is less specific, inhibiting other 
membrane-associated ATPases such as the NEM-sensitive factor required for 
vesicle fusion (Block et al., 1988). DCCD reacts with acidic residues in 
hydrophobic environments, and so also inhibits the F-type ATPase (Altendorf,
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1977), however this activity can be eliminated by inclusion of 0.02% sodium azide 
in reactions, effectively making DCCD specific for the V-ATPase. In addition, 
both DCCD and bafilomycin Ai cause the same level of ATPase inhibition in 
purified vacuoles (Harrison et al., 1994; Kane et al., 1989), supporting the use of 
DCCD as a way of overcoming the practical limitations of bafilomycin Ai whilst 
maintaining the specificity of inhibition.
Figure 4.4 shows the specific activities of vacuoles prepared for the various strains 
of yeast, assayed under saturating concentrations of ATP, i.e. at concentrations at 
least ten times greater than the published Michaelis constant (Km) for the enzyme, 
such that the reaction proceeds at near maximal rate and is not affected by 
substrate depletion over its course. In this case, the published Km of the S. 
cerevisiae V-ATPase is 0.2mM (Jones et al., 1995), so 5mM ATP was used. The 
activities are similar to published results (Jones et al., 1995), with both the ductin 
knockout and dominant negative strains showing a loss of activity. However, no 
inhibition of the V-ATPase was seen in any of the E5 protein transformants.
The fact that the E5 proteins do not inhibit the V-ATPase is a little unexpected, 
given that BPV-1 E5 binds at the active site of ductin, the same binding site as 
DCCD (Finbow et al., 1992). One possibility is that the proteins affect the affinity 
of the enzyme for ATP rather that the maximal rate of hydrolysis. To address this 
possibility, the Km for the V-ATPase preparations was determined by repeating 
the enzyme assays using a number of ATP concentrations around the published 
Km. The volume of the reaction was increased to minimise the effects of 
sibstrate depletion over time, and the ATP concentrations chosen so as to be 
equally spaced when plotted on a double reciprocal Lineweaver-Burke graph. The
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action of inhibitors can interfere with kinetic studies, so DCCD was not used to 
determine the specific activity, however the V-ATPase is the principal ATPase in 
the vacuole so the data obtained from this analysis are representative of those for 
the enzyme.
Representative graphs are shown in Figure 4.5 which shows that this form of 
analysis is capable of distinguishing between the effects of the ductin knockout 
and dominant negative expression. A comparison of the maximal enzyme 
activities (Vmax) is shown in Figure 4.6. The results are similar to published 
results (Jones et al., 1995), and those shown in Figure 4.4, being slightly higher 
because they represent the total, rather than the specific V-ATPase activity. This 
effect is most pronounced in the ductin knockout and dominant negative activities 
since the majority of their total activity is attributable to other ATPases. In any 
case, the only samples showing consistent inhibition are the ductin knockout and 
dominant negative, confirming that none of the E5 proteins inhibit the maximal 
rate of hydrolysis by the V-ATPase significantly. However, the possibility still 
remains that they alter the affinity of the enzyme for ATP
i
The Michaelis constant gives an indication of the affinity of the enzyme for a 
substrate. It can be used to detect competitive and uncompetitive inhibition, which 
often have little or no effect upon the Vmax, but reduce the rate of catalysis at 
non-saturating concentrations of substrate. The E5 proteins do not bind at the 
ATP-binding site, so competitive inhibition is not expected, however it is possible 
that their binding to ductin could alter the conformation of the ATP-binding 
subunits, as in the case of bafilomycin Ai, which binds to the Vo sector 
(Landoltmarticorena et al., 1995; Zhang et al., 1994). This irreversible
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uncompetitive inhibition would be expected to alter the Vmax as well as the Km, 
which was not seen, but because the Km and Vmax can be altered to different 
degrees, it is possible that effects may only be revealed from comparisons of the 
Km. The Michaelis constants were calculated from the X intercepts of 
Lineweaver-Burke plots of vacuole activities, and are shown in Figure 4.7.
The dominant negative (Vma3p E137G) strain shows that disruption of the 
proteolipid core does decrease the affinity of the V-ATPase for ATP, interestingly 
an effect not seen in the ductin knockout strain. The reason for this is not known, 
but it could be explained if the dominant negative ductin became incorporated into 
the enzyme, rather than blocking its formation. Because of the tight coupling in 
the enzyme, this disruption of the Vo would impair the binding of ATP, elevating 
the Km. However, since only 40% of the ATPase activity is sensitive to DCCD in 
the strains with an inactivated V-ATPase, these observations could be due to 
other ATPases.
None of the E5 proteins significantly alter the affinity of the V-ATPase for ATP. 
The significance of the p value for BPV-4 E8 is unclear because a similar effect is 
not seen in any of the E8 mutants, including the hypertransforming N17A mutant. 
So it seems that in yeast grown under optimal conditions, the E5 proteins have no 
discernible effect upon proton translocation or ATP hydrolysis by the V-ATPase, 
despite binding in vitro and correct expression in the vacuole in vivo. One 
possibility is that the proteins dissociate from the enzyme when delivered to the 
vacuole, so the in vivo binding of the E5 proteins to the V-ATPase was 
investigated.
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4.4 HPV-16 E5 does not appear to bind to the active V-ATPase in vivo.
HPV-16 E5 was chosen to represent the E5 proteins in this analysis since it is 
capable of transforming a number of cell types (Straight et al., 1993) and can be 
detected by western blotting.
The vacuoles were solubilised in N-dodecyl maltoside, a non-ionic detergent which 
does not denature the V-ATPase (Harrison et al., 1999). In addition, this 
detergent would not be expected to disrupt the E5-ductin interaction in the light of 
it being milder than the detergents in RIPA buffer used during in vitro binding 
assays of the E5-ductin complexes (section 2.2.8.3). The solubilised protein was 
overlaid onto a buffered, continuous gradient of 20%-50% glycerol (w/v), 
containing 0.1% detergent to retain the proteins in solution. The samples were 
centrifuged on a benchtop ultracentrifuge, which allowed faster separation and so 
minimised mixing by diffusion and the inactivation of the enzyme over time. A 
swing out rotor using low rates of acceleration and deceleration was used to 
minimise turbulent mixing. Separation was achieved on the basis of size and 
shape, with large protein complexes (such as the V-ATPase) migrating furthest 
down the gradient. Fractions were collected by upward displacement, again to 
minimise mixing. Whole fractions were precipitated in acetone:ethanol to 
delipidate and concentrate the samples before electrophoresis on a 
polyacrylamide gel. The type of gel used was dependent upon the proteins being 
observed; 10% acrylamide in tris-glycine buffer being the best for resolving the 
large Vphlp subunit, and 15% acrylamide in tris-tricine buffer, according to 
(Schagger and von Jagow, 1987) being used for all other proteins due to its
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resolving power at low molecular weights. The electrophoresed proteins were 
then blotted onto nitrocellulose membrane for immunodetection.
To analyse the separation of proteins in the gradient, and provide a direct 
reference for subsequent immunodetection data, the nitrocellulose membranes 
were stained with Ponceau-S, the results being shown in Figure 4.8. The 
separation of proteins is demonstrated by the banding patterns along the gradient, 
and reveals differences between preparations that contain an active V-ATPase 
and those that do not. This change of protein profile was induceable by 
expression of the dominant negative form of ductin, but not by HPV-16 E5, which 
reinforces earlier results showing that it and the other E5 proteins do not disrupt 
the V-ATPase, or at least not in the same manner as the dominant negative 
ductin.
To compare the activities of the V-ATPase purifications, and provide a second 
point of reference against immunological analysis, the ATPase activities of the 
fractions were determined in the presence of sodium azide (Figure 4.9). The 
restriction of activity to a small number of fractions, compared to the distribution of 
protein throughout the gradient seen in Figure 4.8 demonstrates the purification of 
the enzyme from other vacuolar protein components, and the activity for HPV-16 
E5 supports previous findings that the E5 proteins do not inhibit the V-ATPase.
DCCD and bafilomycin Ai were not used to determine the specific activity since 
they do not inhibit the solubilised form of the enzyme (M. Finbow, unpublished 
results). However, 80% of the total ATPase activity was attributable to the V- 
ATPase before fractionation, and the loss of activity in purifications from both
125
ductin defective strains shows that the activity is linked to that of the V-ATPase. 
Nevertheless, solubilisation causes a 2-fold increase in ATPase activity (Finbow 
and Harrison, personal communication), which may be due to activation of other 
ATPases. These might interfere with the ATPase profile of the gradient, so NEM 
was used to determine the V-ATPase activity more specifically. NEM reacts with 
the cysteine residue at the active site of subunit A (section 1.3.5.2.1), inhibiting the 
V-ATPase. The NEM-sensitive activity is shown in Figure 4.10, revealing activity 
due to other ATPases and identifying the V-ATPase as being present in the 
denser fractions of the gradient.
Antibodies are commercially available against some subunits in the Vo and V| 
components of the yeast V-ATPase, so it was possible to analyse the assembly of 
the enzyme, and the binding of HPV-16 E5 in vivo. Antibodies against the 
catalytic Vi subunit (Vmalp) and the ductin-associated Vo glycoprotein (Vphlp) 
were used to track the position of the enzyme components, and the 12CA5 anti 
HA antibody was used to detect the dominant negative ductin and HPV-16 E5 
proteins. The locations of the three proteins were compared against each other 
and against the location of fractions containing the peak of V-ATPase activity 
(Figure 4.11-Figure 4.14).
Analysis of the wild-type V-ATPase purification in Figure 4.11 shows that the Vo 
and subunits co-localise around the fractions containing the peak of NEM- 
inhibitable ATPase activity, supporting the assertion that this activity is due to the 
V-ATPase. The reactivity in the anti-HA blot may represent a poorly-reacting 
endogenous protein that has been highly concentrated by the purification 
(potentially representing its total occurrence in 1 mg of vacuoles.)
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Figure 4.12 shows the immunoblotting profiles for the ductin knockout strain, the 
lack of V-ATPase subunits agreeing with work showing that ductin is required for 
assembly of both Vt and Vo subunits onto the vacuolar membrane (Kane et al., 
1992). Figure 4.13 shows a similar picture for the dominant negative transformant, 
but the occurrence dominant negative ductin peak in the same fractions as those 
seen for the holoenzyme in Figure 4.11, suggests that the dominant negative form 
of ductin is incorporated into a large protein complex. Because none of the other 
V-ATPase subunits are present, it is unlikely that the migration of ductin is due to 
its incorporation into the V-ATPase, however it is possible that it forms aggregates 
with itself, supported by the occurrence of larger immunoreactive species on the 
blot.
If HPV-16 E5 was integrated into the enzyme similar to the dominant negative 
form of ductin, a similar anti-HA profile would be seen, however, Figure 4.14 
shows that this is not the case. Some HPV-16 E5 is present in the same fractions 
as the peak of ATPase activity, but the majority is found in lighter fractions. These 
fractions would appear to contain only scant amounts of ATPase activity, which 
may be attributable to other ATPases.
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4.5 Summary
All of the E5 proteins bound to S. cerevisiae ductin in vitro and were correctly 
expressed in the vacuole, but subsequent analysis showed that this interaction did 
not affect:
• The growth of yeast in liquid culture
• The growth of yeast in conditions requiring an active V-ATPase
• The maximal catalytic rate of the V-ATPase
• The affinity of the V-ATPase for ATP
• The assembly of the V-ATPase
Western blot analysis suggested that HPV-16 E5 did not remain associated with 
the enzyme in vivo, which would be consistent with these observations, however 
studies in mammalian cells suggest that the E5 proteins do inhibit the V-ATPase 
(Schapiro et ai., 2000; Straight et al., 1995). One possibility is that the E5 proteins 
only exert subtle effects on the enzyme, and that a more sensitive system is 
required to detect their effects in yeast. This can be achieved by changing the 
carbon source upon which the yeast strains are grown, which causes partial 
dissociation of the V-ATPase (Kane, 1995) and so may sensitise the enzyme to 
the effects of the E5 proteins.
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Figure 4.1 Representative growth curves of S. cerevisiae strains expressing 
the E5 proteins
To check for V-ATPase independent toxic effects of the E5 proteins, optical densities of 
exponential-phase cells were monitored over 8 hours of growth in minimal glucose medium buffered 
to pH 5.5. The ductin knockout strain, W303-1B Vatc, and the ductin dominant negative, Vma3p 
E137G are included as vacuole-defective controls and show reduced growth rates.
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Figure 4.2 Growth rates of S. cerevisiae strains grown in minimal glucose 
medium
Doubling times were calculated from logarithms of the average growth rates, converted to base 2. 
This allowed statistical analysis of the growth rates, and also the calculation of inoculation densities 
for exponential phase culture preparation. The ductin knockout strain (W303-1B Vatc), and the 
ductin dominant negative (Vma3p E137G) show that vacuolar inactivation retards growth, but this 
effect is not seen for any of the E5 proteins, suggesting that they do not affect vacuolar function.
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Figure 4.3 Screening for V-ATPase defects in wild-type yeast in glucose 
medium
Transformed strains of YPH 500 were streaked onto plates of complete and minimal glucose 
medium. 100mM calcium chloride and 100mM MOPS-CI pH 7.5 were used to screen for vacuolar 
defects. The ductin knockout strain, W303-1B Vatc and the dominant negative ductin transformant, 
Vma3p E137G were used as positive controls. Medium buffered to pH 5.5 confirms that the 
phenotypes are pH or calcium dependent. The plates represent results from experiments repeated 
three times, the growth of the E5 protein expressing strains showing that they do not inactivate the 
V-ATPase.
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Figure 4.4 V-ATPase assay of YPH 500 strains expressing the E5 proteins
To quantify the effects of the E5 proteins on the V-ATPase, the vacuoles were purified by floatation 
on 8% Ficoll and the amount of V-ATPase activity determined by DCCD inhibition in the presence of 
0.02% sodium azide. Glucose concentrations were maintained at 2% for 3 hours before lysis of the 
spheroplasts to minimise starvation-induced dissociation of the enzyme. The dominant negative 
form of ductin inactivated the V-ATPase but this effect was not seen for any of the E5 proteins.
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Figure 4.5 Lineweaver - Burke plot of representative enzyme activities
To allow more detailed kinetic analysis, activities were obtained for a range of ATP concentrations 
around the published Km of the V-ATPase and plotted on a double reciprocal graph. The Y and X  
intercepts were used to calculate the Vmax and Km respectively. This plot distinguishes between 
the ductin knockout and dominant negative strains, but does not reveal any effects of HPV-16 E5.
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Figure 4.6 Maximal V-ATPase activity as determined by Lineweaver-Burke 
kinetic analysis
The Y intercepts of Lineweaver-Burke plots of enzyme activities were used to calculate the maximal 
rate of catalysis. None of the E5 proteins inhibited the V-ATPasae by the same amount seen in 
strains with a defective V-ATPase.
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Figure 4.7 ATP affinity determined by Lineweaver-Burke analysis
To check for uncompetitive inhibition by the E5 proteins, the Km was determined from the X  
intercept of Lineweaver-Burke plots of enzyme activity. The dominant negative form of ductin 
appeared to increase the Km. BPV-4 E8 seemed to produce a similar effect, but this was not seen 
for any other of the E5 proteins.
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Figure 4.8 V-ATPase assembly in as revealed by Ponceau-stained blots
Vacuolar membranes were prepared from wild-type yeast transformants grown in complete glucose 
medium. Total fractions from 20%-50% glycerol-gradient purifications of 1mg aliquots of vacuolar 
membranes were precipitated by acetone:ethanol and run on 15% tris-tricine polyacrylamide gels. 
These were electroblotted onto nitrocellulose and stained with Ponceau S. V-ATPase inactivation 
produces differences in protein profile, but this was not seen for HPV-16 E5.
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Figure 4.9 ATPase activity of fractions obtained by glycerol gradient 
purification of vacuolar membranes
To locate the fractions containing the V-ATPase in the glycerol gradient purifications, the ATPase 
activity was determined for 10\jJ  aliquots of the fractions collected from 20%-50% glycerol gradient 
purifications of 1 mg aliquots of vacuoles solubilised in N-dodecyl maltoside. All reactions contained 
0.02% sodium azide to annul any contaminating F-ATPase activity.
137
00
(O
in
to
eoa.o
CO
oo inco
(uiui/in/div siouiu) Ai!A|ioe esediv
Fr
ac
tio
n 
nu
m
be
r
Figure 4.10 NEM inhibition of the purified V-ATPase
100\iM NEM was used to confirm that the activity peak is due to the V-ATPase. The majority of 
the activity was due to the V-ATPase, but the peak of activity seemed to be centred between 
fractions 7 and 8.
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Figure 4.11 Western blot analysis of purified V-ATPase fractions from YPH 
500 bearing the empty pYPMA expression vector
Whole fractions from glycerol gradient purifications were precipitated with acetone:ethanol and run 
on a 10% tris-glycine polyacrylamide gel, (15% tris-tricine for anti-HA blots to enhance resolution). 
Electroblotting was carried out for 2 hours, including 20% methanol in the transfer buffer only for 
anti-HA and anti-Vmalp blots. The fractions containing peak V-ATPase activities are denoted by 
asterisks. The HA immunoreactivity is most likely to be an artefact produced during blotting, since it 
is not seen in any of the other enzyme purifications.
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Figure 4.12 Western blot analysis of purified V-ATPase fractions from the 
W303-1B Vatc yeast strain
Methodology was as for YPH 500 vacuoles. The absence of activity and enzyme subunits agrees 
with the expected lack of assembly.
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Figure 4.13 Western blot analysis of purified V-ATPase fractions from wild- 
type yeast expressing the dominant negative form of ductin
Methodology was as for YPH 500 vacuoles. The reduction in the levels of the Vo glycoprotein 
suggest that the dominant negative ductin inhibits assembly of the Vo, the presence of larger 
species suggetsing that it forms aggregates, which may explain its migration into the gradient.
141
Anti Vphlp (Vo glycoprotein)
105 ►
75 ►
Anti Vmalp (catalytic subunit)
75 — ►
50 — ►
3 5 — ►
3 0 — ►
Anti HA (dominant negative ductin)
Molecular 
mass 
(kDa)
3 5  ►
3 0 ---- ►
2 5  ►
1 5 ----►
10 — ►
1 2 3 4 5 6 7 8 9  1011
Figure 4.14 Western blot analysis of purified V-ATPase fractions from wild- 
type yeast expressing the HA-tagged HPV-16 E5 protein
Methodology was as for YPH 500 vacuoles. HPV-16 E5 was located in different fractions to those 
containing V-ATPase activity and enzyme subunits, suggesting that the protein is not associated 
with the enzyme in vivo.
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5. Results: Analysis of the effects of viral E5 proteins on 
the S. cerevisiae V-ATPase supported by galactose/ 
raffinose
5.1 Introduction
Another feature with using yeast is that the assembly and activity of the V-ATPase 
can be modulated by carbon source. The V| sector rapidly dissociates from the 
Vo sector in response to glucose removal from the medium (Kane, 1995). This 
also occurs when glucose is replaced by other carbon sources such as raffinose, 
and overnight growth in raffinose results in only partial reassembly of the enzyme 
(Kane, 1995). The carbon source also affects the activity of the enzyme (Figure 
5.1), with transfer to galactose/raffinose initially causing the same level of 
inactivation as the ductin knockout. However, even after prolonged growth in 
galactose and raffinose the activity is only restored to a third of its level in glucose 
medium.
This compromisation of the V-ATPase by carbon source may sensitise it to the 
effects of the E5 proteins, so the activity of the enzyme was assessed under these 
restrictive growth conditions using the same techniques as those for glucose- 
based medium.
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5.2 Galactose/raffinose supports growth of all yeast strains at a reduced 
rate, but does not reveal any effects of the E5 proteins
Firstly, to confirm that YPH 500 respond in the same manner described by (Kane, 
1995), the V-ATPase activity was determined under a variety of nutrient conditions 
(Figure 5.1). Cells grown and spheroplasted in the presence of glucose had the 
expected, high levels of activity, however if the same culture was spheroplasted in 
the presence of galactose/raffinose, the activity fell to the levels comparable to 
that of the ductin knockout. Growth of cells in galactose/raffinose prior to 
digestion in galactose/raffinose resulted in partial restoration of activity, to 
approximately 30% of that when prepared using glucose. This is consistent with 
the enzyme disassembly seen by (Kane, 1995), so to maintain a constant level of 
enzyme compromisation all cultures were grown in the presence of 
galactose/raffinose for 7 days before being studied.
The growth of the dominant negative ductin strain at high calcium concentrations 
(Figure 4.3) despite its loss of V-ATPase activity (Figure 4.4) suggests that the 
enzyme can tolerate a certain degree of disruption before complete loss of 
function. It is also apparent that the E5 proteins do not disrupt the enzyme to the 
same extent as the dominant negative form of ductin, however growth in 
galactose/raffinose may provide a means of sensitising the V-ATPase to their 
effects.
Experiments in glucose medium have shown that the E5 proteins are neither toxic, 
nor able to induce the ‘petite’ phenotype (Figure 4.2). To assess whether this was 
the case when the activity V-ATPase is partially compromised and its activity
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markedly reduced, the growth of exponential-phase cultures grown in pH 5.5- 
buffered galactose/raffinose growth medium was followed (Figure 5.2). The 
cultures were sensitive to dilution in the medium, so use of identical inoculation 
densities produced different starting densities for the experiment. However, all 
cultures were grown for 16 hours before analysing so the ‘lag’ phase of growth 
should have been completed.
Analysis of the doubling times, shown in Figure 5.3, reveals that all strains grew at 
approximately half of that in glucose (Figure 4.2), and that the effects of vacuolar 
inactivation were more pronounced, suggesting that galactose/raffinose sensitises 
the cells to the effects of V-ATPase disruption. However, the E5-expressing 
strains grew at the same rate as the wild type, supporting previous observations 
that they are neither toxic or able to induce the petite phenotype through effects 
on the V-ATPase.
5.3 Growth on galactose/raffinose increases the stringency of vacuolar 
screening but does not reveal any effects of the E5 proteins
A more stringent assessment of vacuolar function under conditions of reduced V- 
ATPase assembly was carried out by screening on galactose/raffinose-based 
solid medium containing 100mM calcium chloride or MOPS chloride buffered to 
pH 7.5. All strains were acclimatised to galactose/raffinose for one week before 
inoculation to prevent screening effects due to loss of V-ATPase activity upon 
change of carbon source.
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Just as the growth rate in liquid medium is lower in galactose/raffinose, so was the 
growth rate on solid medium; colonies taking up to one week to appear compared 
to two days when grown on glucose. Figure 5.4 shows that unlike on glucose 
medium, the dominant negative transformant fails to grow on complete medium 
containing calcium when maintained on galactose/raffinose, suggesting that the 
overall level of stringency has been increased by the change of carbon source.
As seen in experiments carried out in glucose (Figure 4.3), the E5 protein- 
expressing strains grew as efficiently as the wild type, suggesting that the proteins 
do not inhibit the V-ATPase. There did appear to be a slight reduction in growth 
rate when screened at pH 7.5 in minimal medium but this was not consistently 
observed, and the nature of this type of experiment meant that this observation 
could not be quantified. However, because yeast vacuoles can be isolated in 
sufficient quantity to permit kinetic analysis of the V-ATPase, it was possible to 
analyse the effects of the E5 proteins on the enzyme in more detail.
5.4 The viral E5 proteins do not inhibit the V-ATPase of cells supported on
I
galactose/raffinose
Growth on galactose/raffinose reduces the population of assembled V-ATPase by
an unknown mechanism (Parra and Kane, 1998). This disassembly only occurs in
catalytically competent enzymes, so may work in synergy with enzyme inhibitors to
deactivate the V-ATPase population. The growth patterns in galactose/raffinose
medium show that this restrictive carbon source does sensitise the vacuole to
disruption, but that the E5 proteins do not perturb proton translocation sufficiently
to compromise the function of the vacuole. By determining the activity of V-
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ATPase isolates, the effects of these proteins could be measured more 
accurately.
As for growth rate determination, all yeast cultures were grown in 
galactose/raffinose medium for one week prior to inoculation and overnight 
culture. Galactose/raffinose concentrations were maintained at 2% (w/v) at all 
stages three hours prior to lysis, to avoid starvation-induced dissociation of the 
enzyme. Vacuoles were isolated and the V-ATPase activity assayed, the results 
being shown in Figure 5.5. The activities were between a third and a half of those 
obtained in glucose medium (Figure 4.4), with the dominant negative ductin 
inactivating the enzyme. However, no inhibition was seen in any strains 
expressing the E5 proteins, supporting the emerging picture that these proteins do 
not contribute towards cell transformation by inhibiting the V-ATPase.
5.5 Summary
Replacement of glucose for galactose/raffinose in the growth medium caused a 
transient loss of V-ATPase activity, which is partially restored over time. Yeast 
strains grown on galactose/raffinose grew at a slower rate than on glucose, and 
also exhibited lower levels of V-ATPase activity in their vacuoles; the latter effect 
sensitising the vacuole to inactivation by expression of a dominant negative form 
of ductin. Despite this sensitisation, none of the E5 proteins had any discernible 
effect on the V-ATPase, so it seems that if these proteins do perturb activity of the 
enzyme, then a further level of compromisation is needed to allow detection.
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Figure 5.1 V-ATPase modulation by carbon source
Overnight cultures of S. cerevisiae grown in glucose or galactose/raffinose minimal medium were 
harvested and transferred to minimal medium containing either glucose or galactose/raffinose for 
two hours. Cells were then harvested and converted into spheroplasts in the presence of the same 
carbon source. Vacuoles were isolated and assayed for V-ATPase activity revealing that 
galactose/raffinose initially causes inactivation of the V-ATPase, but activity is partially restored 
after prolonged growth.
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Figure 5.2 Growth curves of S. cerevisiae strains supported on medium 
containing galactose/raffinose
To check for V-ATPase independent toxic effects of the E5 proteins in yeast grown under restrictive 
conditions, optical densities of exponential-phase cells were monitored over 8 hours of growth in 
minimal galactose/raffinose medium buffered to pH 5.5. The ductin knockout strain, W303-1B Vatc, 
and the ductin dominant negative, Vma3p E137G are included as vacuole-defective controls and 
show reduced growth rates.
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Figure 5.3 Growth rates of S. cerevisiae strains grown in minimal 
galactose/raffinose medium
Doubling times were calculated from logarithms of the average growth rates, converted to base 2. 
This allowed statistical analysis of the growth rates, and also the calculation of inoculation densities 
for exponential phase culture preparation. The ductin knockout strain (W303-1B Vatc), and the 
ductin dominant negative (Vma3p E137G) show that vacuolar inactivation retards growth, but this 
effect is not seen for any of the E5 proteins, suggesting that they do not affect vacuolar function in 
yeast with a partially compromised V-ATPase.
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Figure 5.4 Screening for V-ATPase defects in wild-type yeast in 
galactose/raffinose medium
Representative results of three experiments where transformed strains of YPH 500 were streaked 
onto selective plates of complete and minimal galactose/raffinose medium. The ductin knockout 
strain, W303-1B and the dominant negative ductin transformant, Vma3p E137G were used as 
positive controls. Non-selective plates buffered to pH 5.5 confirm that the phenotypes are pH and 
calcium dependent. All of the strains expressing the E5 proteins grew under selection showing that 
they do not cause inactivation of the partially compromised V-ATPase.
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Figure 5.5 V-ATPase assay of wild type yeast transformants grown in 
minimal galactose/raffinose medium
Vacuoles were isolated by floatation on 8% Ficoll and assayed for V-ATPase activity by measuring 
the rate of DCCD-inhibitable ATP hydrolysis in the presence of 0.02% sodium azide. 
Galactose/raffinose concentrations were maintained at 2% for 3 hours before lysis of the 
spheroplasts to minimise starvation-induced dissociation of the enzyme. The enzyme activity was 
lower than that when glucose was used as a carbon source, illustrating the compromisation of the 
enzyme, but none of the E5 proteins affected the activity in the same way as that of dominant 
negative ductin.
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6. Results: Investigation using a highly compromised V- 
ATPase transgenic for Nephrops ductin and grown on 
galactose/raffinose.
6.1 Introduction
So far, it has been shown that the E5 proteins do not inhibit the V-ATPase under 
optimal or restrictive growth conditions. The possibility still remains that their 
effects are too subtle to be seen by analysis of the native form of the enzyme, and 
that a less stable form may exaggerate their effects, it being more liable to 
dissociate or lose activity in some way upon E5 binding..........................................
To this end, a strain of yeast expressing a histidine-tagged form of the Norway 
lobster (Nephrops norvegicus) ductin was used to investigate the E5 proteins. 
Nephrops ductin complements for yeast ductin but doubles the Km of the V- 
ATPase, the inclusion of a hexahistidine tag causing a further 5 fold increase 
(Harrison et al., 1994), qualitatively compromising the enzyme in addition to the 
quantitative effects from growth in galactose/raffinose. As with Vma3p, it has 
been well established that all four E5 proteins bind to Nephrops ductin in vitro 
(Figure 6.1), (Ashrafi eta l., 2000; Faccini etal., 1996), (I. Rodriguez, manuscript in 
preparation). In addition, preliminary results from work carried out by L. Meagher 
and M. Finbow suggested that the BPV-1 E5 and HTLV-1 p12* are capable of 
inhibiting this Nephrops transgenic V-ATPase (Figure 6.2).
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This study extends upon those results, using the original pYES2-based plasmid 
construct to conserve the properties of the system, but with a thorough 
investigation into the effects of all of the E5 proteins, exploiting the availability of 
antibodies to Nephrops ductin to determine the nature of in vivo associations.
6.2 Nephrops ductin partially restores vacuolar function, but does not 
reveal any effects of the E5 proteins.
Despite the published ability of Nephrops ductin to restore the activity of the V- 
ATPase, this could not be achieved consistently with the yeast stocks held in our 
laboratory (data not shown). The reason for this is not known, but the loss of 
activity appeared to be a consequence of the age of the stocks and might be 
explained by mitochondrial loss over time due to the ‘pet’ phenotype described in 
section 4.2. Both the ductin knockout and the Nephrops transgenic strain 
exhibited this phenotype (M. Finbow, personal communication) but although this is 
only a partial phenotype in V-ATPase-defective strains (Supek et a/., 1994), 
perhaps the length of storage caused total mitochondrial loss, restricting ATP 
production further and thus the ability of the cells to support a large population of 
active V-ATPases.
Nonetheless, because only partial restoration of V-ATPase activity is sufficient to
restore the function of the vacuole, Nephrops ductin may be able to restore the
growth of yeast under selective conditions. So to test this, and also to screen for
effects of the E5 proteins, galactose/raffinose cultures were inoculated onto solid
galactose/raffinose medium buffered to pH 5.5 and 7.5. Figure 6.3 shows the
results of these selective plates spread with yeast strains bearing combinations of
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Nephrops ductin and viral E5 proteins. All colonies grew very slowly, taking up to 
two weeks to appear under selection, and despite its inability to restore growth 
rates in liquid medium (data not shown), Nephrops ductin restored the ability to 
grow at high pH in complete medium, confirming its reconstitution of the yeast V- 
ATPase. (Calcium plates were not as effective in distinguishing the effects of the 
Nephrops protein, perhaps due to the prolonged growth periods required, so were 
omitted).
No growth occurred on minimal medium buffered to pH 7.5, marking the functional 
threshold of the transgenic V-ATPase and demonstrating the additional level of 
compromisation in this system. As expected, the dominant negative form of yeast 
ductin prevented growth under selection, but none of the E5 proteins had any 
effect, despite the increased sensitivity of the system.
To further investigate the reconstitution of the V-ATPase by Nephrops ductin, the 
enzyme was purified through a glycerol gradient as described in section 2.2.7.1 
and the ATPase activities determined in each of the fractions (Figure 6.4). The 
results show that Nephrops ductin does restore a small amount of ATPase 
activity, but the different activity profile to the wild type enzyme (Figure 4.10) 
suggests that the activity is not due to the V-ATPase; the activity is found in less 
dense fractions than the V-ATPase. This ATPase activity could be due to the 
vesicle-associated NEM-sensitive factor (Block et al., 1988). However, this 
ATPase activity seems to be dependent upon restoration of the V-ATPase since it 
is not seen in either the ductin knockout or dominant negative ductin strains. 
Because the activity is present in the strain expressing HPV-16 E5 it again 
suggests that the E5 proteins do not perturb the activity of the V-ATPase.
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To test if Nephrops ductin restored the assembly of the V-ATPase, and to 
determine the nature of its interaction with dominant negative ductin and HPV-16 
E5 in vivo, the purified fractions were probed by western blotting.
6.3 Western blot analysis of the purified Nephrops ductin reveals enzyme 
reconstitution and differences in the behaviour of HPV-16 E5 in vivo.
The fractions from glycerol gradient purifications were concentrated and subjected 
to SDS-PAGE and western blotting, as detailed in section 4.4. The locations of 
the catalytic V| subunit (Vmalp), Nephrops ductin and HA-reactive proteins are 
shown in Figure 6.5 - Figure 6.8.
Figure 6.5 shows the protein profiles for the ductin knockout strain, with no V- 
ATPase subunits or E5 proteins being detected in the vacuole, as seen when the 
same experiment was performed using glucose in the growth medium (Figure 
4.12).
Figure 6.6 shows that the expression of Nephrops ductin increases the levels of 
the catalytic Vi subunit in the same fractions as those of the wild type enzyme 
(Figure 4.11), but separate from those containing the ATPase activity (Figure 6.4), 
further suggesting that this activity does not represent that of the V-ATPase. The 
correct mass of Nephrops ductin shows that it is expressed correctly and targeted 
to the vacuole, and its appearance in the same fractions as the catalytic Vi 
subunit, and of those fractions containing V-ATPase activity in the wild type 
enzyme (Figure 4.10) are consistent with data showing it being capable of 
reconstituting the V-ATPase (Figure 6.3), (Harrison etal., 1994).
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Figure 6.7 shows that both the Nephrops and dominant negative yeast ductin are 
located in the same fractions, so are likely to be incorporated into the same 
complexes; their co-migration with the catalytic Vi subunit suggesting 
incorporation into the V-ATPase. The catalytic Vi subunit did not appear in 
purifications of the wild type enzyme in the presence of dominant negative ductin 
(Figure 4.13), the most likely explanation being suppression of the effects of the 
dominant negative due to the elevated levels of Nephrops ductin expression on 
the pTY plasmid compared to those of wild type ductin.
From work with the wild type enzyme, HPV-16 E5 appeared not to bind to the V- 
ATPase in vivo, on the basis that it was not found in the same fractions as those 
containing other V-ATPase subunits (Figure 4.14). However, when this 
experiment was repeated for the Nephrops ductin V-ATPase, HPV-16 E5 was 
present in fractions containing Nephrops ductin and the catalytic V! subunit 
(Figure 6.8), and in fractions which contained V-ATPase activity in the wild type 
enzyme (Figure 4.10). In addition, HPV-16 E5 shows a lower tendency to form 
aggregates in the Nephrops ductin system.
This suggests that its migration into the gradient is by way of its association with 
another large protein complex (such as the V-ATPase), as opposed to forming 
large complexes of itself, so it is possible that HPV-16 E5 does bind to the 
Nephrops transgenic V-ATPase in vivo, however there are fractions where HPV- 
16 E5 and Nephrops ductin are found separately, suggesting that the two proteins 
do not form a stable association. In either case, the activity of the enzyme is 
unaffected, dissociating the binding activity of HPV-16 E5 from direct inhibition of 
the enzyme.
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6.4 Summary
Nephrops ductin restores the function of the V-ATPase as assessed by growth at 
high pH and assembly of the purified enzyme. The failure to restore growth in 
minimal medium at high pH demonstrates the slim margin by which function has 
been restored, and thus the sensitivity of the system to V-ATPase perturbation. 
Despite this sensitivity, none of the E5 proteins affected the activity of the enzyme.
These results agree with those obtained from experiments with a fully active and 
partially compromised V-ATPase, suggesting that E5 proteins do not directly 
inhibit the V-ATPase in the vacuole.
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Figure 6.1 In vitro binding of the E5 proteins to Nephrops ductin
Representative figures from data published by (Ashrafi et ai, 2000; Faccini et a!., 1996) and I. 
Rodriguez (Manuscript in preparation) demonstrating the ability of the E5 proteins to bind to 
hexahistidine-tagged Nephrops ductin. The E5 proteins were co-translated with Nephrops ductin in 
the presence of microsomes and radiolabelled cysteine, then immunoprecipitated with antibodies to 
their respective epitope tags, the co-precipitation of the proteins demonstrating their association.
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Nephrops ductin
BPV-1 E5
Nephrops ductin 
HTLV-1 p12'
Nephrops ductin
HPV-16 E5
Nephrops ductin
Figure 6.2 Inhibition of the Nephrops transgenic V-ATPase in strains
expressing the E5 proteins
Vacuoles were isolated from S. cerevisiae strains transgenic for Nephrops ductin by M. Finbow and 
L  Meagher, the inactivation seen in the E5 and p121-expressing strains suggesting that these 
proteins were capable of inhibiting the V-ATPase.
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Figure 6.3 Screening for V-ATPase defects Nephrops ductin transgenic
yeast strains expressing viral E5 proteins
Representative results of three experiments where transformed W303-1B Vatc strains were 
streaked onto selective plates of complete and minimal galactose/raffinose medium. The ductin 
knockout strain, W303-1B Vatc contains no form of ductin, and the dominant negative ductin 
transformant, Vma3p E137G was used as a positive control for inhibition. Non-selective plates 
buffered to pH 5.5 confirm viability of the yeast strains, plates buffered to pH 7.5 screen for vacuolar 
defects. Calcium plates were omitted because their stringency was below that of pH plates and 
gave no additional data. Nephrops ductin restored vacuolar function, but not sufficiently to permit 
growth in minimal medium buffered to pH 7.5. Despite this level of compromisation, no effects of 
the E5 proteins were seen.
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Figure 6.4 ATPase activity of fractions obtained by glycerol gradient 
purification of vacuolar membranes
1mg aliquots of TE-washed vacuoles were separated on a 20%-50% glycerol gradient into 11 
fractions. ATPase activity was calculated from the rate of ATP hydrolysis in the presence of 0.02% 
sodium azide. ATPase activity was restored by Nephrops ductin expression, but in a different 
location to that of the wild type V-ATPase, suggesting that the activity is attributable to another 
enzyme.
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Figure 6.5 Western blot analysis of purified V-ATPase fractions from the 
W303-1B ductin-knockout yeast strain bearing the empty pYPMA expression 
vector
Whole fractions were precipitated with acetone:ethanoi and run on a 10% tris-glycine 
polyacrylamide gel, (15% tris-tricine for anti-HA blots to enhance resolution). Electroblotting was 
carried out for 2 hours including 20% methanol in the transfer buffer.
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sFigure 6.6 Western blot analysis of purified V-ATPase fractions from the 
W303-1B Vatc yeast strain expressing Nephrops ductin and bearing the 
empty pYPMA expression vector
Methodology was as for W303-1B Vatc vacuoles. Nephrops ductin is detected by western blotting, 
and the presence of the catalytic \/r subunit suggests that it restores assembly of the V-ATPase.
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Figure 6.7 Western blot analysis of purified V-ATPase fractions from the 
W303-1B Vatc yeast strain expressing Nephrops ductin and the dominant 
negative form of ductin
Methodology was as for W303-1B Vatc vacuoles. Contradictory to results obtained for the wild type 
enzyme, the appearance of catalytic V1 subunit suggests that the dominant negative form of S. 
cerevisiae ductin does not block assembly of the Nephrops ductin V-ATPase.
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Figure 6.8 Western blot analysis of purified V-ATPase fractions from the 
W303 1B-Vatc yeast strain expressing Nephrops ductin and the HA-tagged 
HPV-16 E5 protein
Methodology was as for W303-1B Vatc vacuoles. HPV-16 E5 is found in fractions that contain 
Nephrops ductin and catalytic \Z* subunit suggesting that it remains bound to the Nephrops ductin 
V-ATPase in vivo.
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7. Discussion
The E5 proteins are a family of small, structurally-related hydrophobic 
transforming proteins. They all bind to ductin, a proteolipid component of the gap 
junction and the vacuolar ATPase (V-ATPase) but the effects of this binding are 
unknown. Both of these complexes are thought to be involved in growth control 
(Eghbali et al., 1991; Mellman, 1992), but gap junctions are also composed of 
connexins and their precise role in cell transformation is unclear. Two of the E5 
proteins have been shown to inhibit functions associated with the V-ATPase 
(Schapiro et al., 2000; Straight et al., 1995), so it was suggested that they directly 
inhibit the enzyme through their association with ductin.
Because of the practical limitations associated with using mammalian cells, it has 
not been possible to study the direct effect of these proteins on the V-ATPase. 
These problems are circumvented if yeast is used as the model organism since V- 
ATPase inhibition can be tolerated by lowering the pH of the growth medium, 
standard protocols exist for large scale vacuole purification, and subsequent study 
of the V-ATPase is aided by the availability of antibodies to many of the subunits. 
The yeast V-ATPase is also almost identical in composition to that in mammalian 
cells and yeast ductin shares 71% sequence identity with mammalian forms of 
ductin.
Although yeast is not the natural host of the viruses which encode the E5 proteins, 
the activities of the proteins in mammalian cells have been well characterised, and 
the intention of this study was to determine the effects of the E5 proteins on the V-
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ATPase in isolation of any of their other effects upon cells. In fact, the differences 
between yeast and mammalian cells could be beneficial since yeast cells do not 
express the same growth factor receptors found in mammalian cells, eliminating 
any competitive effects due to these proteins.
This study addresses for the first time the question of whether the E5 proteins 
inhibit the V-ATPase through their binding to ductin. Epitope-tagged E5 proteins 
were analysed for their ability to bind Saccharomyces cerevisiae ductin in vitro, 
and to perturb the activity of the V-ATPase in vivo, using successive levels of V- 
ATPase compromisation to aid the detection of subtle effects. Western blot 
analysis of the purified V-ATPase was also performed to test for their ability to 
perturb assembly of the V-ATPase, and also for their ability to bind to the V- 
ATPase in vivo.
The growth characteristics of the strains expressing the dominant negative and 
Nephrops forms of ductin demonstrate the different levels of screening that can be 
achieved by varying the carbon source and enzyme composition. Although no 
effects of the E5 proteins on the vacuolar function were revealed, this is the first 
time that these successive levels of stringency have been demonstrated, which 
may prove useful in future studies of the V-ATPase.
All of the E5 proteins were correctly expressed, and bound to S. cerevisiae ductin 
in vitro. The correct expression of the dominant negative ductin and HPV-16 E5 in 
the vacuole was shown by western blotting, and that of the other E5 proteins was 
inferred from the specific detection of HA-tagged protein by dot blotting, their 
correct expression in vitro, and detection of the correct plasmid constructs in vivo.
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The reason why the proteins were not detected by western blotting, and possible 
solutions were discussed in section 3.3.
7.1 The E5 proteins appear to dissociate from the V-ATPase in vivo
Despite binding to ductin in vitro (Figure 3.2), none of the E5 proteins perturbed 
the activity of the V-ATPase in any of the systems tested. One explanation for this 
may lie in the differences of in vivo binding behaviour of HPV-16 E5 in wild type 
and Nephrops transgenic yeast strains, (Figure 7.1). In the wild type system, 
HPV-16 E5 was not found in fractions possessing V-ATPase activity or containing 
enzyme subunits. However, in the Nephrops transgenic system, HPV-16 E5 
migrated differently, being found in fractions containing both ductin and subunit A, 
suggesting that it remains bound to the enzyme.
An attempt was made to confirm the in vivo association of HPV-16 E5 with 
Nephrops ductin in the vacuole (data not shown), exploiting the hexahistidine tag 
to purify the protein using Nickel chelated to nitrilotriacetic acid (Ni-NTA), 
reviewed by Crowe et ai., (1994). This overcomes the practical restrictions 
associated with the production of radiolabelled vacuolar material prior to 
immunoprecipitation, and the expense of immunoprecipitation and western 
blotting of unlabelled vacuolar material. Unfortunately, the purification method is 
designed for hydrophilic proteins, and the columns appeared to bind hydrophobic 
proteins regardless of whether they possessed a hexahistidine tag. Were 
sufficient antibody and vacuolar material available, the in vivo association of the 
HPV-16 E5 with ductin and the V-ATPase could be probed in detail by
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immunoprecipitation and western blotting of individual fractions from purifications 
of the wild type and chimeric V-ATPase.
Direct observations of rotational catalysis by the F-ATPase showed that the 
enzyme is capable of generating high levels of torque (Noji et al., 1997). This 
torque is suggested to drive the rotation of the critical acidic residue past static 
subunit a (Jiang and Fillingame, 1998). As the V-ATPase shares structural and 
mechanistic features with the F-ATPase, it seems likely that a similar torque will 
be generated in the ductin complex of Vo which is sufficient to dislodge any 
proteins associated with ductin in the V-ATPase. In addition, if the conformational 
changes seen upon deprotonation of the Fo subunit c (Rastogi and Girvin, 1999) 
also occur in ductin, which seem likely given the high levels of structural homology 
between the two proteins in this region (Pali et al., 1999; Harrison et al., 
manuscript submitted), then this means that the BPV-1 E5 binding site will be 
altered during catalysis (Figure 7.2). Therefore, the active V-ATPase may cause 
the E5 proteins to dissociate from ductin. However, the situation may be different 
in the Nephrops transgenic strain since the Km for ATP is 10 times that of the wild 
type enzyme and there could be partially active V-ATPase complexes which 
contain E5 proteins. Nevertheless, even this possibility does not appear to inhibit 
V-ATPase activity (Figure 6.3).
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YPH 500 + HPV-16 E5
W303-1B Vatc + Nductin + HPV-16 E5
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1 2 3 4 5 6 7 8 9  1011
Subunit A
V-ATPase activity
Figure 7.1 HPV-16 E5 appears to dissociate from the active V-ATPase
Comparison of HPV16-E5 localisation with respect to ductin in wild type and Nephrops ductin 
transgenic Saccharomyces cerevisiae. The location of the two forms of ductin and HPV-16 E5 are 
revealed by western blotting, and demonstrate differential migration of HPV-16 E5 in the two 
systems.
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Ductin
Vphlp
Figure 7.2 Rotational catalysis may cause the dissociation of the E5 
proteins from ductin
The organisation of the subunits in the Vo sector of the V-ATPase is inferred from that of the F- 
ATPase (Rastogi and Girvin, 1999). Ductin is depicted as a four-helix bundle forming a hexameric 
complex, and the static glycoprotein Vphlp is coloured in green. If the scheme of rotational 
catalysis is correct, then the ductin hexamer rotates past Vphlp to cause proton translocation, 
changing conformation as it does so, indicated by the red and purple helices. This conformational 
change would also affect the proposed BPV-1 E5 binding site (indicated with an asterisk) which, 
coupled with the amount of torque generated by the F-ATPase (Noji et al., 1997) may be sufficient 
to disrupt the binding of the E5 proteins.
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The dissociation of the E5 proteins is consistent with their inability to inhibit the V- 
ATPase and is reminiscent of the association between the Vma12/Vma22p 
complex with Vphlp. Vphlp is a membrane protein component of the V-ATPase 
but far from causing inhibition of the enzyme, the binding of the Vma12p/Vma22p 
assembly complex is actually required for its activity (Graham et al., 1998). 
Interestingly, Vma12p is of similar size and hydrophobicity to BPV-1 E5 (Jackson 
and Stevens, 1997), and also appears to dissociate from the active V-ATPase 
(Graham etal., 1998).
So if the conclusions presented in this thesis are correct, that the E5 proteins do 
not disturb the activity of the wild type or chimeric V-ATPase, how are the 
observations that expression of BPV-1 E5 and HPV-16 E5 cause alkalinisation of 
the Golgi and early endosome respectively (Schapiro et al., 2000; Straight et al.,
1995) accounted for? One explanation may lie in the fact that neither yeast nor 
Nephrops are the natural host of the papillomaviruses. However, given the high 
sequence conservation of ductin, and that all of the E5 proteins tested so far bind 
to yeast Vma3p and Nephrops ductin, this seems unlikely. Therefore, it is more 
likely that the disturbance of the Golgi and endosome pH is a secondary effect of 
the E5 proteins.
7.2 Alternative mechanisms of V-ATPase inhibition by the E5 proteins
BPV-1 E5 could inhibit Golgi and vacuolar acidification indirectly (Figure 7.3 G, H),
for example Golgi alkalinisation has been observed in response to stimulation of
protein kinase A or protein kinase C (Seksek et al., 1995). These kinases are
involved in the PDGF-R signalling pathway (deBlaquiere et al., 1994; Li et al.,
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1994) but transformation of cells with upstream elements of this pathway (the s/s 
and src oncogenes) did not have any effect on the pH of the Golgi (Schapiro et al., 
2000). The pH of the Golgi and the vacuole was not determined in the 
transformed yeast strains, but the accumulation of red adenine precursors and 
growth at pH 7.5 (Figure 4.3) suggested that vacuolar function was not 
compromised.
BPV-1 E5 requires Golgi localisation to cause cell transformation (Sparkowski et 
al., 1995). Because it, and all of the other E5 proteins are so small, they may lack 
targeting information that would allow them to exit the ER. Ductin binding might 
therefore be a mechanism by which the E5 proteins escape the ER (Figure 7.3 A), 
with rotational catalysis of the V-ATPase ensuring their release, so that they can 
interact with other cellular targets.
Although Golgi alkalinisation correlates with cell transformation by BPV-1 E5 
(Schapiro et al., 2000), ductin binding does non always correlate with cell 
transformation (Sparkowski et al., 1995; Sparkowski et al., 1996) which is also 
found for BPV-4 E8 and HTLV-1 p121 (Ashrafi et al., 2000; Koralnik et al., 1995). 
Further evidence that the E5 proteins do not transform cells by directly inhibiting 
the V-ATPase comes from studies using the specific V-ATPase inhibitor, 
bafilomycin Ai on cultured mammalian cells.
Bafilomycin A  ^ was found to inhibit all aspects of receptor downregulation: 
endocytosis, degradation and recycling (Harada et al., 1996; Johnson et al., 1993; 
Yoshimori et al., 1991), whereas BPV-1 E5 only inhibited degradation (Waters et 
al., 1992), and HPV-16 E5 caused only a delay in internalisation and degradation,
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and was actually found to increase the rate of recycling (Straight et al., 1993). 
These studies, as well as those that demonstrated compartmental alkalinisation 
effects of the E5 proteins (Schapiro et al., 2000; Straight et al., 1995) 
acknowledged that a direct study would be required to prove that the effects on 
the enzyme were not due to secondary effects of the proteins. Alternative 
explanations were also proposed, for example that BPV-1 E5 alters the affinity of 
EGF-R for EGF (Waters et al., 1992), or that HPV-16 E5 binding to ductin retards 
the delivery of the V-ATPase to endosomes (Straight et al., 1995).
High levels of bafilomycin Ai are cytotoxic (Ohkuma et al., 1993), but although 
BPV-4 E8 is cytotoxic in the absence of other transforming proteins (Pennie et al., 
1993) overexpression of BPV-1 E5 is not (Burkhardt et al., 1989). Bafilomycin A-\ 
and HPV-16 E5 have also been studied in respect of their effects on cell 
morphology and migration (Thomsen et al., 1999). Although both inhibited cell 
mobility, they had different effects upon cell morphology, and the cooperativity of 
their effects upon motility led to the suggestion that they affected the V-ATPase in 
different ways, or that the action of HPV-16 E5 was indirect.
7.3 Possible mechanisms of cell transformation by the E5 proteins
The data presented in this thesis suggest that the E5 proteins do not directly 
inhibit the V-ATPase. An alternative reason for binding to ductin has already been 
discussed, as has the possibility of indirect inhibition of the activity of the V- 
ATPase. There are also a number of ways in which the proteins could transform 
cells independently of their effects upon the V-ATPase, summarised in Figure 7.3.
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Most of the E5 proteins bind to growth factor receptors (Hwang et al., 1995; Mulloy 
et al., 1996; Petti and DiMaio, 1992). Although the role of receptor binding for 
BPV-1 E5 and HPV-16 E5 is disputed (Conrad et al., 1994; Sparkowski et al.,
1996), perhaps this binding and subsequent stimulation of mitogenic activity 
(Figure 7.3 D, J) represents one part of their transforming activity. BPV-1 E5 has 
also been shown to bind to p125, an a-adaptin protein involved in endocytic 
vesicle formation (Cohen et al., 1993b) suggesting that it may be able to slow the 
rate of receptor downregulation independently of effects on the V-ATPase (Figure
7.3 B), but the effects of this interaction have yet to be shown.
The perturbation of EGF-R processing in BPV-1 E5-expressing cells (Waters et 
al., 1992) may have been due to disruption of the endocytic pathway by inhibition 
of the V-ATPase, but one of the original suggestions was that E5 expression 
altered the affinity of EGF-R for its ligand, which in turn reduced the rate at which 
it was processed (Waters et al., 1992). One possibility is that the alkalinisation of 
the Golgi by BPV-1 E5 prevented protein maturation (Figure 7.3 I), causing 
immature growth factor receptors to be expressed at the cell surface which are 
more resistant to degradation than the mature forms. Disruption of protein 
maturation in the Golgi has also been suggested to hinder the presentation of 
major histocompatibility complexes on the cell surface, enabling BPV-1 to escape 
detection by the immune system (Schapiro et al., 2000). It may also be that the 
binding of E5 is what alters the affinity to produce a similar resistance to 
degradation (Figure 7.3 E), which is consistent with the increased rate of recycling 
seen for HPV-16 E5 expression (Straight et al., 1993).
176
In addition to its roles in the V-ATPase, gap junction and mediatophore, ductin has 
been shown to bind to Printegrin (Skinner and Wildeman, 1999). The binding site 
is the same as that for BPV-1 E5, so perhaps the E5 proteins compete with, and 
inhibit the binding of Pi-integrin to ductin (Figure 7.3 C). In addition to this, the 
PDGF signalling pathway is thought to converge with integrin-mediated signalling 
at the focal adhesion (Figure 7.3 F), (Rankin and Rozengurt, 1994), which has 
been suggested to explain some of the activities of the E5 proteins (Skinner and 
Wildeman, 1999) and may explain the incomplete correlation seen between the 
various binding activities and transforming potencies (Ashrafi et al., 2000; 
Sparkowski etal., 1995; Sparkowski etal., 1996).
Integrins link the cytoskeleton to the extracellular matrix (Sastry and Horwitz, 
1993) so it was interesting to see that the cellular morphology and contact effects 
could be altered by overexpression of a form of ductin lacking the fourth helix 
(Skinner and Wildeman, 1999), and that BPV-1 E5 expression alters actin 
distribution (Bergman et al., 1988), which is normally regulated by integrins 
(Defilippi etal., 1999).
Actin is involved in maintenance of the ER and the Golgi, and is suggested to be 
involved in endosomal vesicle transport (Lamaze et al., 1997), reviewed by 
DePina and Langford, (1999) so perhaps the cytoskeletal disruption by E5 is what 
causes the changes in vesicle transport and in the Golgi apparatus.
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Figure 7.3 Possible modes of action of the E5 proteins
Ductin binding may represent a mechanism to escape the ER (A) whence it disrupts cellular activity 
directly (B, C, D) or indirectly (E, F, G, H, I), the eventual effect being to stimulate cell division (J).
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7.4 Further work
Despite structural similarities, and the conserved ductin binding of the E5 proteins, 
it is not known if they transform cells by the same mechanism. For example, it is 
not known if BPV-4 E8 binds to growth factor receptors, and the ductin-binding 
domain of HTLV-1 p121 has been shown not only to be dispensable, but to be 
located in a different region to that of BPV-1 E5 (Koralnik et al., 1995). It might 
therefore, be useful to determine if the proteins share a common mechanism 
before continuing with their investigation, by determining if they can be functionally 
interchanged.
A similar approach could be used to determine their mode of action. Dominant 
negative ductin has been shown to promote anchorage-independent growth 
(Andresson et al., 1995), as did an internalisation-defective EGF-R mutant (Wells 
et al., 1990). If single or multiple combinations of these proteins could overcome 
the requirement for E5 proteins for normal viral function, then their relative 
contributions to the mode of E5 protein action could be determined.
The interaction of the E5 proteins with ductin could be studied more extensively in
S. cerevisiae. In addition to the suggestion in section 7.1, expression of epitope
tagged forms of wild-type, human and bovine ductin alongside the epitope-tagged
E5 proteins would allow immunoprecipitation in order to determine the extent of
interaction in a number of cellular locations, which would indicate if ductin
represents their final target or if it acts as an intermediate. The suggestion that
the E5 proteins are dislodged by rotational catalysis by the V-ATPase could be
tested by determining the V-ATPase activity of these compartments and
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correlating this with the level of binding. Alternatively, VPH1 and VMA11 mutant 
strains capable of V-ATPase assembly but not catalysis, as used by (Parra and 
Kane, 1998) could be used to determine if catalysis causes dissociation of the E5 
proteins.
To test the hypothesis that ductin binding is a mechanism of escaping the ER, the 
effects of mutations that disrupt the ductin binding ability of the E5 proteins could 
be studied in respect of their effects upon the cellular localisation of the E5 
proteins in the cell. Similarly, if this mechanism of exiting the ER is a common 
feature of small hydrophobic proteins, it may be interesting to see if there are 
other such proteins that bind to ductin, for example, viral proteins which have been 
shown to exhibit sequence similarities with the E5 proteins (Garry, 1995).
7.5 Summary
The work presented in this thesis demonstrates the usefulness of yeast for 
studying the V-ATPase, and shows that the E5 proteins do not directly inhibit the 
V-ATPase in the vacuole, nor remain associated with the active enzyme. This 
suggests that observations of compartment alkalinisation (Schapiro et al., 2000; 
Straight etal., 1995) are due to indirect effects, and that the interaction with ductin 
may serve another purpose.
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